Skip to content
naulon

No retraction, correction or concern found when last checked on Oct 15, 2026.

Toxic Mechanisms of Five Heavy Metals: Mercury, Lead, Chromium, Cadmium, and Arsenic

Mahdi Balali-Mood, Kobra Naseri, Zoya Tahergorabi and 2 more

Frontiers in Pharmacology · 2021 · Review · CC BY

doi:10.3389/fphar.2021.643972

Abstract

The industrial activities of the last century have caused massive increases in human exposure to heavy metals. Mercury, lead, chromium, cadmium, and arsenic have been the most common heavy metals that induced human poisonings. Here, we reviewed the mechanistic action of these heavy metals according to the available animal and human studies. Acute or chronic poisonings may occur following exposure through water, air, and food. Bioaccumulation of these heavy metals leads to a diversity of toxic effects on a variety of body tissues and organs. Heavy metals disrupt cellular events including growth, proliferation, differentiation, damage-repairing processes, and apoptosis. Comparison of the mechanisms of action reveals similar pathways for these metals to induce toxicity including ROS generation, weakening of the antioxidant defense, enzyme inactivation, and oxidative stress. On the other hand, some of them have selective binding to specific macromolecules. The interaction of lead with aminolevulinic acid dehydratase and ferrochelatase is within this context. Reactions of other heavy metals with certain proteins were discussed as well. Some toxic metals including chromium, cadmium, and arsenic cause genomic instability. Defects in DNA repair following the induction of oxidative stress and DNA damage by the three metals have been considered as the cause of their carcinogenicity. Even with the current knowledge of hazards of heavy metals, the incidence of poisoning remains considerable and requires preventive and effective treatment. The application of chelation therapy for the management of metal poisoning could be another aspect of heavy metals to be reviewed in the future.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 15, 2026. Paragraph numbers are ours, so an answer can point at one.

Introduction

Heavy metals have harmful effects on human health, and exposure to these metals has been increased by industrial and anthropogenic activities and modern industrialization. Contamination of water and air by toxic metals is an environmental concern and hundreds of millions of people are being affected around the world. Food contamination with heavy metals is another concern for human and animal health. Concentration of heavy metals in water resources, air, and food is assessed with this regard. Metals among the other environmental pollutants may also occur naturally and remain in the environment. Hence, human exposure to metals is inevitable, and some studies have reported gender differences in the toxicity of metals. They may frequently react with biological systems by losing one or more electrons and forming metal cations which have affinity to the nucleophilic sites of vital macromolecules. Several acute and chronic toxic effects of heavy metals affect different body organs. Gastrointestinal and kidney dysfunction, nervous system disorders, skin lesions, vascular damage, immune system dysfunction, birth defects, and cancer are examples of the complications of heavy metals toxic effects. Simultaneous exposure to two or more metals may have cumulative effects. High-dose heavy metals exposure, particularly mercury and lead, may induce severe complications such as abdominal colic pain, bloody diarrhea, and kidney failure. On the other hand, low-dose exposure is a subtle and hidden threat, unless repeated regularly, which may then be diagnosed by its complications, e.g., neuropsychiatric disorders including fatigue, anxiety, and detrimental impacts on intelligence quotient (IQ) and intellectual function in children. The fact that several metals have emerged as human carcinogens is another important aspect of the chronic exposure. While the exact mechanism is unclear, aberrant changes in genome and gene expression are suggested as an underlying process. Carcinogenic metals such as arsenic, cadmium, and chromium can disrupt DNA synthesis and repair. The toxicity and carcinogenicity of heavy metals are dose dependent. High-dose exposure leads to sever responses in animal and human which causes more DNA damage and neuropsychiatric disorders. The toxic mechanism of heavy metals functions in similar pathways usually via reactive oxygen species (ROS) generation, enzyme inactivation, and suppression of the antioxidant defense. However, some of them cause toxicities in a particular pattern and bind selectively to specific macromolecules. Different toxic mechanisms of heavy metals increase our knowledge on their harmful effects on the body organs, leading to better management of animal and human poisonings. We aimed to review the literature on the toxicity mechanisms associated with heavy metals, which will increase our knowledge on their toxic effects on the body organs, leading to better management of the metal poisonings.

Methods

This review provides context and specific overview of the currently available research data on the toxic mechanisms of heavy metals. It was aimed at reviewing the toxic effects and mechanisms of five main heavy metals including mercury, lead, cadmium, chromium, and arsenic. Current study intended to discuss and compare the data on toxic mechanisms from main scientific databases including PubMed, Web of Science (ISI), Scopus, and Google Scholar. The search terms included “mercury,” “lead,” “cadmium,” “chromium,” “arsenic,” “toxicity,” “poisoning,” “intoxication,” “mechanism of toxicity,” “mechanism of action,” and “cancer”. The literature was searched for animal and human studies involving acute and chronic exposures to the five metals and any related harmful adverse effects to body organs. Letter to the editor and unpublished data were excluded. Toxic mechanisms for each metal were extracted from the literature. Their similarities and differences were compared (Table 1).

Mercury (Hg)

Mercury (Hg) is found in air, water, and soil and exists in three forms: elemental or metallic mercury (Hg0), inorganic mercury (Hg+, Hg2+), and organic mercury (commonly methyl or ethyl mercury). Elemental mercury is liquid at room temperature and can be readily evaporated to produce vapor. Mercury vapor is more hazardous than the liquid form. Container breakage causes Hg0 spills and inhaling large amounts of Hg vapor can be fatal. Organic mercury compounds such as methyl mercury (Me-Hg) or ethyl mercury (Et-Hg) are more toxic than the inorganic compounds. The order of increasing toxicity related to different forms of mercury is defined as Hg0 < Hg2+, Hg+ < CH3-Hg. Mercury compounds have many applications in mining for example extraction of gold and some industrial processes. In lamp producing factories, Hg is used in the production of fluorescent light bulbs. Me-Hg and Et-Hg have been used as fungicides to protect plants against infections. Moreover, mercury has had medicinal uses in the past, but such drugs have been replaced by safer pharmaceutical medicines. Some examples are chlormerodrin, merbaphen, and mercurophylline (all diuretics) and phenylmercury nitrate (disinfectant). Besides, some skin lightening creams and some soaps are mercury polluted. Mercury chloride (HgCl2) is one of the active ingredients of skin brightening creams which are used to remove freckles and spots of the skin due to excessive accumulation of melanin. HgCl2 inhibits tyrosinase activity irreversibly, an enzyme which functions in melanin formation, by replacing the copper cofactor. Further, a mercury-containing organic compound called thimerosal has been used as a preservative in multidose vials of vaccines. Hg0 (vapor) is readily absorbed from lungs (80%) and distributed throughout the body. Hg0 can pass the blood brain barrier (BBB) and placenta; thus, its neurotoxicity is higher than inorganic Hg which passes through membranes at a slower rate. Hg0 is oxidized in the body to produce divalent Hg (Hg2+). Hg0 (liquid) is slightly absorbed from the gastrointestinal (GI) tract and does not appear to be toxic. Inorganic Hg is concentrated in the kidneys—reabsorbed from proximal tubules as Cys-S-Hg-S-Cys or basolateral membrane by organic anions transporters. Inorganic Hg cannot pass the BBB and placenta. Organic Hg is easily absorbed from the GI tract (95%) and distributed throughout the body. CH3-Hg is bound to thiol-containing molecules such as cysteine (CH3-Hg-Cys) so that it can pass the BBB. Hair is considered as an index of Hg exposure since CH3-Hg is accumulated there. Other than hair, Hg is excreted in urine and feces. CH3CH2-Hg follows similar pharmacokinetics to CH3-Hg.

Animal Studies

In an animal model of acute toxicity, exposure to Hg vapor (550 μg/m3) resulted in mercury deposits in different parts of the brain and also in the spinal cord. Vapor exposure can cause a 70% increase in brain metallothionein, a metal binding protein, in the mice. demonstrated cognitive impairment and hippocampal damage in rats with oral chronic administration of HgCl2. They also found that mercury levels in the hippocampus increased to 0.04 μg/g while the control group had Hg concentrations less than 0.01 μg/g. Another study indicated methylmercury chloride induced CNS injury in rats receiving different doses of 0.05, 0.5, and 5 mg/kg Hg against normal saline group. CNS damage was showed via the increased expression of c-fos protein in cortex and hippocampus as an important signal transduction pathway. Hg accumulation in the brain was also observed in treated rats. Chronic mercury vapor exposure can cause renal injury. Investigation of kidney tissues of Wistar rats exposed to 1 mg/m3 Hg vapor per day revealed histological alteration of the kidneys after 45 days. However, the renal Hg deposition might be slow by the inhibition of γ-glutamyltranspeptidase, resulting in increased urinary Hg concentration. The basis for such reduction refers to the role of γ-glutamyltranspeptidase in the reuptake of mercury-glutathione conjugate in glomerulus. Following renal injury related to HgCl2, the antioxidative system of the rat kidney is compromised. Decreasing glutathione peroxidase activity and increased contents of oxidative lipids and proteins occurred as well as morphological changes in renal tissue 72 h after intoxication. Only 4 days of oral exposure to Hg compounds (HgCl2 and Me-HgCl) in rats caused intestinal fluid accumulation, mucosal injuries, and diarrhea. Administration of Hg (5 mg/kg) reduced mRNA and downregulated aquaporins in the rat gastrointestinal tract. Impaired aquaporins expression seems to be involved in the GI tract harmful effects related to Hg intake. Hg-induced hepatotoxicity was shown in an HgCl2 treatment animal model. The hepatotoxicity of mercury was determined by histopathological analysis and investigating elevated liver enzymes level including alanine transaminase (ALT), aspartate transaminase (AST), and alkaline phosphatase (ALP). An Hg-induced hepatotoxicity study showed gender differences in Wistar rats and female rats had higher levels of Hg accumulation in the liver. It was suggested that sex-dependent effects of liver damage via Hg exposure be related to the organic anion transporter 3 (Oat3). Male rats showed decreased expression of Oat3. The decrease in the Oat3 abundance will limit Hg intake into the liver, leading to lower hepatotoxicity in males. It seems that the organic anion transport is regulated by sex hormones. showed that the expression of Oat3 protein is strongly elevated by testosterone. The expression of these transporters may be regulated by sex hormones. Hormone-dependent expression of Oat3 transporter might be responsible for these differences. proposed that activation of the Nrf2 signaling pathway could be effective to prevent liver lesions induced by Hg. ROS production reduces in this way and thus oxidative stress decreases.

Human Studies

Microorganisms in marine environments perform natural biomethylation reactions to produce Me-Hg. Me-Hg enters the food chain of aquatic animals and eventually enters the human body through the consumption of fish. Cooking fish does not diminish its Hg content. An incident of exposure to organic Hg via the consumption of contaminated fish occurred in Minamata Bay, Japan, in the middle of 1950s. Soon afterward, the illness came to be known as Minamata disease. Chronic Hg toxicity caused neurological damage including ataxia, muscle weakness, numb limbs, disturbance in speech, chewing, and swallowing, and brisk and increased tendon reflex among the patients exposed to massive amounts of Me-Hg. Infants with severe developmental disabilities were born from the poisoned pregnant women. Lethal Hg intoxication is usually due to the accidental exposure. Findings of neural electromyography among 104 people who had occupational exposure to mercury, with median urinary Hg concentration of 88.5 μg/g creatinine, manifested chronic injuries to peripheral nerves. Hg preferentially accumulates in the kidneys and exerts deleterious effects especially in the proximal tubules. investigated the effects of Hg exposure on nonalcoholic fatty liver disease in 6,389 adolescents aged 12–17 years. The median blood Hg level was 0.73 ± 0.91 μg/L and a mild ALT elevation was observed. The relationship between blood Hg concentrations and the level of liver enzymes including ALT, AST, and gamma glutamyl transferase (GGT) was significant especially in elderly population (>60°years). Moreover, there is a potentiation effect with regular alcohol drinking and high blood Hg concentration. This might be explained by oxidative stress, impairment of cellular metabolism, and cell death due to liver damage via Hg exposure, leading to an elevation in the liver enzymes, especially in GGT level. In a cross-sectional study, the level of liver enzymes changed by the increase in blood Hg levels. The relationship between GGT and blood Hg concentration was significant, suggesting that GGT may be considered an early oxidative stress marker for mercury exposure. Two studies in China evaluated renal effects of Hg exposure among inhabitants near to mercury mines which were highly Hg polluted areas and found elevated levels of serum creatinine and urea nitrogen in comparison to those in the control areas. Hg-induced renal function impairment was revealed to be higher in females and the elderly people. Maternal exposure in such areas also could cause impaired renal function.

Lead (Pb)

Lead is a harmful environmental pollutant which has high toxic effects to many body organs. Even though Pb can be absorbed from the skin, it is mostly absorbed from respiratory and digestive systems. Pb exposure can induce neurological, respiratory, urinary, and cardiovascular disorders due to immune-modulation, oxidative, and inflammatory mechanisms. Furthermore, Pb could disturb the balance of the oxidant–antioxidant system and induce inflammatory responses in various organs. Exposure to Pb can produce alteration in physiological functions of the body and is associated with many diseases. Pb is highly toxic which has adverse effects on the neurological, biological, and cognitive functions in the bodies. The international level-of-concern for Pb poisoning is 10 μg/dl in the blood. Adulteration of opium with Pb has been considered as a threat to human health in recent years.

Animal Studies

Daily administration of lead acetate (PbA) (15 mg/kg, ip) for 2 weeks in pregnant Wistar female rats induced proinflammatory cytokines including IL-1β and TNF-α in the hippocampus and IL-6 in the forebrain of immature rat brain. These results suggested that chronic lead exposure causes inflammation in the central nervous system (CNS) of immature rat brain which might be through activation of glial cells. Lead exposure (0.1–0.4 MPb) increased serum endothelin-1 (ET-1), serum nitric oxide (NO), and eosinophil peroxidase (EPO) accompanied with lung pathological changes in ovalbumin (OA) sensitized and nonsensitized guinea pigs. Exposure to PbA (0.1–0.4 MPb) increased serum total protein, histamine, and total and differential white blood cells (WBC) counts of guinea pigs. Hematological effects of chronic toxicity of the PbA (0.4%) in drinking water for 12 weeks in adult male rats showed significantly decreased red blood cells (RBC) count, while increasing total and differential WBC counts. Subchronic exposure to Pb at 10 and 100 times the normal concentrations via drinking water in rats increased activities of AST, ALP, and levels of urea nitrogen and creatinine. Besides, exposure to Pb induced necrotic changes in brain, liver, and kidneys. Intraperitoneal administration of PbA (10 mg/kg, bw) to induce hepatotoxicity in rats enhanced hepatocyte abnormalities and increased acid phosphatases (APs), ALP, AST, ALT, and lactate dehydrogenase (LDH) levels. Exposure of rats to PbA significantly reduced antioxidant parameters such as glutathione peroxidase (GPx), catalase (CAT), superoxide dismutase (SOD), and glutathione S-transferase (GST) and decreased glutathione (GSH) content in hepatocytes and erythrocytes. In addition, Pb significantly increased oxidative parameters including malondialdehyde (MDA) and H2O2 concentrations as well as expression of cyclooxygenase-2 (COX-2). Adult male rats exposed to PbA (500 mg/L) showed significant elevation in the levels of serum ALT, AST, urea, uric acid, and creatinine. PbA also increased lipid peroxide and reduced GSH, SOD, CAT, and GPx levels in liver and kidney tissues of induced animals. Administration of Pb (1 mg/kg, bw, ip.) in rats for a period of 4 weeks significantly increased lipid peroxide level in the liver, but antioxidant parameters such as SOD and CAT activities did not change statistically. Subcutaneous administration of PbA (100 mg/kg, bw) in rats increased the levels of lipid peroxidation (LPO) including MDA and 4-hydroxyalkenals (4-HDA) levels in the liver and kidneys compared to the control animals. Moreover, PbA decreased SOD and total GSH in the liver and kidneys of rats. Administration of PbA in rat diet (500 mg/kg/day) for 2, 4, and 6 weeks resulted in the elevations of serum ALT, AST, GGT, and ALP activities and hepatic necroinflammatory lesions. Lead also induced hepatocyte proliferation, portal inflammatory infiltrate, steatosis, apoptosis, and mild fibrosis 6 weeks after administration. It has been reported that PbA (500 mgPb/L) in drinking water promoted apoptosis by activation of mitochondria cytochrome C release and inhibited Bcl-2 proteins and activation of caspase-3 in kidneys of the exposed rats. In a study, administration of PbA (25 mg/kg, bw, ip.) for 5 days in rats increased urea and creatinine levels while it decreased total protein and albumin in the serum. The reduction of antioxidant parameters including GPx, CAT, and SOD and induction of hyperlipidemia resulted from lead induced toxicity. Furthermore, hemorrhage in the renal tubules, degeneration in epithelial cells, disruption of Bowman’s capsule, and necrosis area in kidney tissue were observed. Orally administered PbA (30 and 60 mg/kg, bw) 3 days in a week for 3 months in rats reduced testicular weight, sperm count, and testicular ALP activity. PbA also induced abnormal sperm count, seminiferous tubules necrosis, and disappearance of seminiferous tubular epithelium in a dose-dependent manner.

Human Studies

Anemia may develop with Pb poisoning via the inhibition of ferrochelatase and δ-aminolevulinic acid dehydratase (ALAD), the two of many enzymes involved in heme biosynthesis (Figure 1). The inhibition of ferrochelatase and ALAD by lead decreases heme synthesis which leads to anemia. Several antioxidant molecules such as GSH and GSSG as well as antioxidant enzymes including SOD, CAT, GPx, and glutathione reductase (GR) may have fluctuations due to Pb exposure and consequent oxidative stress. Pb has high affinity to the reactive –SH group of GSH and is able to decrease the GSH levels. GPx, CAT, and SOD are metalloproteins that their antioxidant functions to detoxifying free radicals could be affected due to Pb exposure. Lead can induce oxidative damage in different organs via direct effect on membrane lipid peroxidation and reducing antioxidant parameters. It has been reported that low level of lead exposure exerts immunostimulating effects in contrast to higher exposure that usually leads to immunosuppression. The results of a study showed that lymphocyte proliferation to phytohemagglutinin (PHA) is inhibited in Pb exposed population compared to the unexposed subjects. However, there was no correlation between inhibition of lymphocyte proliferation and blood lead level (BLL). In addition, Pb exposure did not affect natural killer (NK) cell cytotoxicity compared to the control group. On the other hand, interferon-γ (IFN-γ) was significantly elevated in Pb exposed individuals. It was shown that there was a significant positive correlation between BLL and IFN-γ level. The immunological effects of lead exposure on lymphocyte proliferation, IFN-γ production, and NK cell cytotoxicity in occupational Pb exposed subjects including wheeler drivers (30), battery workers (34), silver jewelry makers (20), and unexposed healthy subjects (30) were studied. The results showed that lymphocyte proliferation to PHA is inhibited while IFN-γ significantly increased in stimulated peripheral blood mononuclear cells (PBMCs) compared with control subjects. The pulmonary function tests (PFT) and respiratory symptoms in 108 battery manufacturing workers and 100 control subjects were evaluated. The lead concentrations in serum and urine of workers were significantly higher while the PFT values were significantly lower than the control group. In addition, the frequencies of respiratory symptoms including chest tightness (26%), cough (17%), and sputum (16%) were significantly higher in battery manufacturing workers compared to the control group. The association between BLL, serum immunoglobulin E (IgE), eosinophil count, and prevalence of asthma in a cross-sectional study of 1,788 children in 2005–2006 was investigated. The results of this study indicated an association between IgE and eosinophilia with lead exposure. The association of BLL to risk of developing asthma was studied in 4,634 children (1–3 years) from 1995 through 1998. It was found that BLL ≥ 5 μg/dl was not associated with asthma among African Americans while there was a slight but not significant association among Caucasians. The relationship between blood and urine lead concentrations and clinical manifestations in car battery manufacturing workers showed a weak correlation between serum ALP and BLL in these workers. Pb exposure on 30 automobile workers remarkably increased blood (364%) and urinary (176%) lead levels compared to the control subjects. Systolic blood pressure (SBP), diastolic blood pressure (DBP), and total white blood cell count (11.44%) were increased in the automobile workers as compared to the controls. Also, red blood cell count, hemoglobin (Hb), hematocrit (Hct), mean corpuscle volume (MCV), and mean corpuscle hemoglobin (MCH) were significantly decreased in workers compared to the control group. Moreover, reported the association of chronic exposures to high occupational Pb with atherosclerosis and cardiovascular mortality.

Chromium (Cr)

Chromium (Cr) is found in the earth’s crust and seawater and is a naturally occurring heavy metal in industrial processes. Cr has multiple oxidation states ranging from −2 to + 6, in which the trivalent and hexavalent forms are the most common stable forms. Cr (VI) is related to a series of diseases and pathologies while Cr (III) is required in trace amounts for natural lipid and protein metabolism and also as a cofactor for insulin action. Based on the International Agency for Research on Cancer (IARC) report (2018), hexavalent chromium has been classified as a group I occupational carcinogen. In this context, a meta-analysis of 973,697 workers involving 17 standardized incidence ratios (SIRs) from seven countries and four kinds of occupations found that 11,564 of them had cancer. The primary route of exposure for nonoccupational human populations occurs via ingestion of chromium containing food and water or dermal contact with products containing chromium. Furthermore, metallurgical, refractory, and chemical industries release a large amount of Cr into soil, ground water, and air which causes health issues in humans, animals, and marine life. Cr can cause a variety of diseases through bioaccumulation in human body. This ranges from dermal, renal, neurological, and GI diseases to the development of several cancers including lungs, larynx, bladder, kidneys, testicles, bone, and thyroid.

Animal Studies

used a mouse model of colorectal cancer to investigate the carcinogenicity of Cr (VI) and As in drinking water. It was found that exposure to Cr and As increased the tumor incidence and size. It was mediated through the Wnt/beta-catenin signaling pathway induced by ROS production. Interactions of ROS and reactive nitrogen species (RNS) with cellular macromolecules such as DNA, lipid, and proteins are considered as one of the main leading causes of toxicity and cancer progress in Cr exposure. In one study by on Sprague-Dawley rats, potassium dichromate was administered intraperitoneally for 5 days at the doses of 2.5, 5.0, 7.5, and 10 mg/kg body weight per day. A significant increase in the levels of ROS and malondialdehyde in liver and kidney along with a dose-dependent increase in superoxide dismutase and catalase activities was reported. Furthermore, after 24, 48, 72, and 96 h after treatment DNA damage was observed in a dose- and time-dependent manner. showed a high risk of brain damage in low doses of Cr on Albino Wistar rats via intranasal exposure. Moreover, higher Cr concentrations caused lung injury. A 2 mg/kg intranasal potassium dichromate resulted in the elevation of oxidative stress biomarkers: interleukin-1β (IL-1β), phosphorylated protein kinase B (PKB), and cyclooxygenase 2 (COX-2).

Human Studies

The results of a recent meta-analysis showed exposure to Cr (VI) may cause increased mortality and incidence of some cancers including lung, larynx, bladder, kidney, testicular, bone, and thyroid cancer in humans. Moreover, an ecological study in 2011 in Greece found high levels of Cr (IV) in drinking water, 41–156 μg/L, and increased incidence of liver (p < 0.001), lung (p = 0.047), and genitourinary cancers (p = 0.025) among women. Another study in 2012 in India showed increased incidence of GI and dermatological complications among population exposed to Cr (VI) contaminated ground water. DNA damage, genomic instability, and ROS generation are accepted as mechanisms of Cr toxicity and carcinogenicity. Both Cr (VI) and Cr (III) are capable of producing ROS. Cr carcinogenicity is followed by DNA damage as disruption of transcription regulation. Furthermore, chromatin architecture is disrupted which causes shifts in chromatin accessibility and local and genome-wide nucleosomal position shifts. Cr-induced DNA damage includes DNA–Cr–protein crosslinks, DNA inter/intrastrand crosslinks, single- and double-strand breaks (SSBs and DSBs, respectively), and p53 point mutations. In vitro studies have demonstrated the ability of Cr (III) to bind nucleic acids. Cr (III) forms binary and ternary DNA adducts. Ternary adducts are predominant and more toxicologically relevant in mammalian cells. Cr (III) ascorbate, Cr (III) cysteine, Cr (III) histidine, and Cr (III) glutathione DNA adducts are four types of ternary adducts. Cr (III) forms DNA–protein crosslinks in human lung adenocarcinoma cells (A549). SSBs and DSBs were found in rapidly dividing cells such as cancer cells as the collapse of replication fork during DNA replication, leading to cell cycle arrest and apoptosis via activation of p53. In one study by Ueno et al. SSBs were detected in the liver and kidney of male albino mice by a single injection of Cr (VI) but there were no significant levels of DNA strand breaks in the spleen, lung, or brain. Hydroxyl radicals generated during the reduction of Cr (VI) by GSH can lead to hydrogen abstraction from the ribose moiety and strand break formation. In general, oxidative DNA damage occurs either by the oxidation states of Cr(V) peroxo intermediates or via ROS action. SSBs, DSBs, and protein-Cr-DNA crosslinks were indicated in the liver cells of F344 rats orally exposed to potassium chromate via drinking water for 3 weeks. Besides, in vivo and in vitro studies demonstrated DNA damage, microsatellite instability, and chromosome aberrations due to Cr (VI) exposure. It seems that factors including the tissue, cell type, Cr (VI) concentration, time of exposure, free radicals formation, and reactivity of the intermediate Cr (V) and Cr (IV) are involved in Cr-induced carcinogenicity. Cr (VI) itself does not bind to macromolecules or DNA instead; the hexavalent cation reacts with cellular reductants to produce Cr (V), Cr (IV), and Cr (III). These metabolic intermediates generated during Cr (VI) reduction trigger Fenton-type reactions which generate hydroxyl radicals in the presence of hydrogen peroxide. Thus, oxidative stress is induced. Furthermore, formation of Cr-Asc (Ascorbate), Cr-GSH, and Cr-cys (cysteine) crosslinks depletes cellular antioxidants and induces oxidative stress. Cr (VI) induced oxidative stress and ROS production in high levels target DNA and lipid content of cells which leads to DNA damage and lipid peroxidation, respectively. Moreover, many other cellular injuries and cell death as both apoptosis and necrosis may occur. ROS production in medium to low levels in cells can lead to tumor formation and progression. One study showed that the reduced-to-oxidized glutathione ratio (GSH/GSSG) is time and dose dependent.

Cadmium (Cd)

Cadmium (Cd), although rare, occurs naturally in soil and minerals such as sulfide, sulfate, carbonate, chloride, and hydroxide salts as well as in water. High levels of Cd in water, air, and soil can occur following industrial activities which could be a substantial human exposure to Cd. Moreover, the ingestion of contaminated food will cause major exposure to Cd. Cd exposure may also occur through smoking, which is capable of elevating blood and urine Cd concentrations. Presence of Cd in contaminated water could disturb the necessary mechanisms in the body, possibly resulting in short-term or long-term disorders. Cd is classified by the International Agency for Research on Cancer (IARC) as carcinogenic to humans (Group 1). Occupational exposure to Cd may occur in alloy, battery, and glass production and in electroplating industries. Due to the importance of the subject, Cd level in the air is routinely monitored in some countries. Rice, grains, and sea food have been found to be polluted by Cd; nonetheless, after oral intake, a small portion of Cd is absorbed. Tragically, the outbreak of Itai-itai disease in Japan was due to the mass Cd contamination of food and water supplies. The patients suffered from painful degenerative bone disease, kidney failure, and the GI and lungs diseases. Unlike low GI absorption, Cd is more efficiently taken from the lungs via industrial dust. Acute or chronic inhalation of Cd in industrial areas might lead to renal tubular dysfunction and lung injuries. Cd blood concentration in smokers is almost twice higher than that of nonsmokers. found Cd blood levels of 0.4 against 1.3 μg/L for nonsmokers vs. smokers in adult population. This seems to be related to the nature of tobacco plants to accumulate relatively high Cd concentrations in tissues especially in the leaves.

Animal Studies

Disorders in the metabolism of Zn and Cu were found in study on rats that were exposed to 1 and 5 mg/kg Cd. It was shown that after a 10-month treatment of female Wistar rats by 1 mg/kg Cd, zinc absorption decreased, while under exposure to 5 mg/kg Cd, its absorption increased after 3 and 24 months. Moreover, after 24-month exposure to 1 mg/kg Cd, Zn concentration in the liver and kidneys increased while spleen concentration of Zn decreased. Following exposure to high dose of Cd (5 mg/kg), after 17 months, Zn concentration increased in spleen and kidneys while its liver concentration was unaffected. Furthermore, in a similar vein, chronic low level and moderate exposure to Cd influenced Cu concentrations in serum and internal organs. On the basis of this experiment, chronic exposure to Cd results in redistribution of essential bioelements which leads to the retention of Zn and Cu in the liver and kidneys and in contrast a decrease in their concentrations in the serum. Cd is taken up into the GI tract through the function of very different transporters. With excessive Cd exposure, the intestinal accumulation increases, particularly in the duodenum. examined the GI absorption of Cd by means of different metal transporters including metallothionein (MT), divalent metal transporter 1 (DMT1), zinc importing protein 14 (ZIP14), Cu-transporting P-type ATPase (ATP7A), and Transient Receptor Potential Vanilloid 6 (TRPV6) in three distinct segments of rats’ intestine. It was found that intestinal concentrations of Cu and Fe decreased in contrast to the increased Cd level. Moreover, the elevation in duodenal Cd exposure caused the increase in the expression of the MTI, MTII, DMT1, ZIP14, ATP7A, and TRPV6 genes. According to their findings, Cd binds to MT and other metal transporters in the small intestine and accumulates in the tissue. As a result, the concentration of both Cu and Fe decreases in the GI and accordingly their absorption into the bloodstream declines. Other studies suggest that Cd decreases the absorption of Zn, Ca, and Cu resulting in the low dietary intake of such essential elements. investigated the molecular mechanisms of Cd nephrotoxicity in rat’s renal cortex. Sprague-Dawley rats received subcutaneous injections of cadmium chloride compound (0.6 mg/kg) for 12 weeks. Afterward, renal cortex miRNA expression was determined. Biochemistry results showed that in contrary to significant increase in urine volume and also the excretion of protein in the urine, urinary creatinine was lower in Cd-treated group. Hence, proximal tubule dysfunction associated with Cd kidney injury causes the development of polyuria and proteinuria. Further, urine microglobulin was significantly higher compared to the control saline group. Molecular assays indicated that Cd dysregulates the miRNA expression; hence, the altered miRNA expression may play a role in Cd-induced nephrotoxicity. The expression of 44 miRNAs was significantly increased while 54 miRNAs were significantly decreased following Cd treatment. Cadmium is known to pose hepatotoxic effects. Depending on the conditions of exposure, its acute toxicity may occur as necrosis or apoptosis. Incubation of rat hepatocytes with 1–5 μmol/L Cd for short exposure times (6-12 h) resulted in apoptosis following cytochrome C release into the cytosol. Endoplasmic reticulum stress and the subsequent cell apoptosis is another proposed path of Cd toxicity. Chronic Cd-induced renal damage mainly involves the damage of glomerulus, especially the proximal tubules. Accumulation of Cd in the epithelial cells of the proximal tubules results in impaired reabsorption function, leading to polyuria, glucosuria, and low molecular weight proteinuria. Cd-induced nephrotoxicity is mediated via oxidative stress, apoptosis, and necrosis. Cd enters the renal epithelial cells either as free or bound forms including Cd-MT, Cd-GSH, and Cd-Cys. Free form is taken up via metal transporters, while the bound forms are taken up via the receptor-mediated pathway. Apart from apoptosis and necrosis, there is evidence that other mechanisms are also involved in proximal tubular injury. Changes in cell–cell adhesion, modulation of cellular signaling pathways, and autophagic responses may occur prior to cell death. The disruption of cell adhesion and cellular signaling cascades, in turn, can trigger autophagic responses in the cells. In a mild injury, the autophagic response may be adequate to repair the damage. However, apoptosis or autophagic cell death can occur in a severe injury. Necrosis of the proximal tubule can occur after widespread cell damage. It is also noteworthy that regardless of Cd uptake mechanism, Cd can accumulate in epithelial cells of the proximal tubule. At high tissue levels of Cd, metallothionein and GSH are overwhelmed, and the cells undergo injury. By the onset of proximal tubule dysfunction apoptosis begins in low number of cells (5%). Many cells undergo Kim-1 upregulation and autophagy. One of the earliest toxic effects of Cd is the disruption of cadherin-mediated cell–cell adhesion. This may cause mild level of oxidative stress. Effect of Cd on cadherin-mediated cell–cell junctions might be due to the interaction with extracellular Ca-binding regions of the macromolecule.

Human Studies

It is understood that Cd produces dispositional tolerance via binding to metallothionein (MT) protein. Such MT induction protects the liver by limiting the distribution of Cd to sensitive cellular macromolecules. However, highly increased levels of cadmium result in unbound and free Cd; hence, the toxic effects occur. presented cadmium levels in human tissues in a ten-year examination in nonpoisoned population. Autopsies were done on brain, stomach, small intestine, liver, kidneys, heart, and the lungs. The lowest level of Cd was in the brain (0.02 μg/g digested samples). High Cd concentrations were measured in kidneys (16.0 μg/g) and liver (1.5 μg/g), as Cd is mainly distributed into these two internal organs. Cd bound to MT is readily taken up by the kidneys. The complex is very toxic for the kidney and is mechanistically involved in the chronic nephrotoxicity of Cd. Cadmium is able to mimic the function and behavior of essential metals. For instance, similar to zinc, Cd binds to albumin in plasma. Consequently, dysregulation of calcium, zinc, and iron homeostasis occurs. Cd-induced liver injury may be associated with the disturbance of calcium (Ca) homeostasis. Disruption of Ca homeostasis induces mitochondrial fragmentation via increased levels of dynamin-related protein 1 (Drp 1). Osteoporosis and bone fracture could be observed following Cd toxicity. In Chen et al. study (2019), comparing residents of two cadmium-polluted areas with a control region showed the association between osteoporosis and high level of Cd intake. Although both men and women showed similar trends, the changes were significant in female population. Cd osteotoxic effects might be due to the decreased levels of serum PTH at high cadmium body burden which in turn induces calcium release from bone tissues. found an inverse association between osteoporosis and the amount of Cd in body. Cd plays a key role in cardiovascular diseases caused by smoking such as peripheral artery disease and coronary heart disease. found association between Cd exposure and the pathway for cardiovascular diseases using mediation analysis in a population of 4,304 middle-aged men and women. They clarified that part of the smoking-induced cardiovascular diseases is mediated through cadmium. Cd may give rise to the occurrence of the kidney, lungs, pancreas, breast, prostate, and GI cancers. A proposed mechanism highlights a sequence of incidents such as ROS generation, elevation of TNF-α level, Nrf2 upregulation, and ultimately aberrant gene expression, deregulation of cell proliferation, and apoptosis resistance. Nephrocarcinogenicity of cadmium might happen after substantial exposure in chemical industries. A hypothesis in this regard explains that the β-catenin signaling pathway plays a role in renal carcinogenesis, including Cd-induced nephrocarcinogenesis. Via this signaling, β-catenin protein which is a transcriptional factor is accumulated in the cytoplasm. Overexpression of β-catenin leads to evasion of ROS-dependent/β-catenin signaling which in turn contributes to carcinogenesis of kidney. Urinary cadmium has been frequently used to assess Cd exposure and the related consequences. Some studies have reported the relationship between prevalence of renal dysfunction or deficit in lung function and measured urinary Cd levels. There might be a dose-response relation in this regard. Beta 2-microglobulin in urine can be considered as a useful marker of tubular proteinuria particularly in Cd-induced toxicity assessments. It has a promising role since there is as low as 360 μg/L beta 2-microglobulin in urine.

Arsenic (As)

Arsenic as a harmful heavy metal is one of the main risk factors for the public health. Sources of As exposure are occupational or via the contaminated food and water. As has a long history of use, either as a metalloid substance or as a medicinal product. It is notoriously known as the king of poisons and poison of kings. As is present as a contaminant in food, water, and environment. Arsenic exists in the forms of metalloid (As0), inorganic (As3+ and As5+), organic, and arsine (AsH3). The order of increasing toxicity of As compounds is defined as organic arsenicals < As0 < inorganic species (As5+ < As3+) < arsine. Primary As absorption is from the small intestine. Other routes of exposure are from the skin contact and by inhalation. Following distribution to many tissues and organs in the body including the lungs, heart, kidneys, liver, muscles, and neural tissue, As is metabolized to monomethylarsonic acid (MMA) and dimethylarsinic acid (DMA) in which the latter is the predominant form in the urinary excretion of As. Acute and chronic As toxicity is related to the dysfunctions of numerous vital enzymes. Similar to the other heavy metals, As can inhibit sulfhydryl group containing enzymes which leads to their dysfunction. Moreover, As inhibits the pyruvate dehydrogenase by binding to the lipoic acid moiety of the enzyme. Pyruvate dehydrogenase inactivation can block the Krebs cycle and inhibits oxidative phosphorylation. As a result, ATP production decreases, resulting in cell damage. Furthermore, the damage of capillary endothelium by As increases vascular permeability, leading to vasodilation and circulatory collapse.

Animal Studies

Oxidative stress and mitochondrial dysfunction may cause neurodegeneration. Two As species, sodium arsenite and DMA, induced apoptosis in cultured neurons of rat brain via activation of p38 and JNK3 MAP kinases, two enzymes that are activated by stress signals and mediate neuron apoptosis. Inorganic As form was more toxic and reduced neuron viability more. Besides, arsenite selectively activated p38 and JNK3 in cerebellar neurons. In a rat hippocampus model, As neurotoxicity was attributed to the altered expression of N-methyl-d-aspartate (NMDA) receptor and changes of molecular expression of postsynaptic signaling proteins. A decline in the expression of NR2A subunit of NMDA receptor and variation in proteins of postsynaptic density protein 95 (PSD-95) and calcium/calmodulin-dependent protein kinase II (p-CaMKII) were observed. ROS generation and cytochrome C release can play a role in the hepatotoxic effects of As exposure. Study of male Wistar rats exposed to As showed oxidative stress and activation of caspase-9, an initiator of the apoptosis signaling. The accumulation of ROS is responsible for lipid bilayer damage which causes mitochondrial swelling. Biochemical analysis of serum of Sprague-Dawley rats showed that As3+ significantly decreased the activity of serum cholinesterase (ChE) in a dose-dependent manner. ChE is an important enzyme for the proper functioning of the nervous system. The decreased ChE activity may be associated with peripheral or CNS injury.

Human Studies

Proinflammatory cytokines TNF-α, IL-6, IL-8, and IL-12 were elevated in the plasma of rural women exposed to low level arsenic. The level of anti-inflammatory cytokine IL-10 was decreased in the exposed population. DNA damage of airway cells was observed following As exposure and the level of DNA adduct 8-hydroxy-2’-deoxyguanosine (8OHdG) was elevated in comparison to the control group. Human studies on the association between As-contaminated drinking water and adverse pregnancy outcomes have shown that As can easily cross the placenta, particularly during early gestation, leading to spontaneous abortion, stillbirth, preterm birth, and low birth weight. The male reproductive system might be impaired through the NF-kB signaling pathway by AS3+. NF-kB cell signaling plays role in spermatogenesis and testis functioning. Arsenic tends to accumulate in the skin. Arsenical keratosis and hyperpigmentation of the skin might occur following As exposure. A cutaneous toxicity study using cultured human keratinocytes showed β1-integrin distribution. Decreased expression in keratinocytes by integrins could result in apoptosis aberration and cutaneous manifestation. Severe cases of intoxication may also develop skin cancer. Oxidative stress, chromosome anomalies, and altered growth factors expression are possible modes of action in As-induced carcinogenesis. As-exposed populations may experience liver lesions. Liver cancers hepatocellular carcinoma and angiosarcoma have been associated with As poisoning. The axon of peripheral nerves continues to degenerate in As neurotoxicity. It is believed that a main cause of As neurological disorders is the ability to cause oxidative stress and mitochondrial dysfunction. Lipid peroxidation induced by oxidative stress leads to DNA damage and ultimately brain cell death.

Exposure to Heavy Metals and Environmental Pollution

Heavy metals induce toxicity to biological systems via bonding to sulfhydryl groups and ROS generation (Figure 2). This causes inactivation of vital macromolecules and the occurrence of oxidative stress and depletion of glutathione. Following exposure to toxic metals and entrance to the body, various processes happen including interaction or inhibition of some metabolic pathways. As a result, numerous harmful effects on humans and animals are observed. These include specific organ dysfunctions, metabolic abnormalities, altered hormones, congenital disorder, immune system dysfunction, and cancer. Therefore, many international organizations set standards regarding the presence of metals in the environment, foods, and drinking water. In risk assessment studies, the presence of heavy metals in food and water is checked. analyzed 193 Ayurvedic medicinal products, famous Indian herbal medicines, and found that about one-fifth contained Hg, Pb, and As. It was found that nearly 21% contained detectable levels of Pb, Hg, and As. Noticeably, all metal-containing products exceeded one or more standards for acceptable daily metal intake. This could result in Pb and/or Hg ingestions 100 to 10,000 times greater than acceptable limits. Besides, the level of metals that can reach the body on a daily basis is regulated. The daily dosage limit for these heavy metals (μg/day) is presented in Table 2. Daily dosage limits for heavy metals in dietary supplements should be established by regulatory authorities. Furthermore, it is required that manufacturers assess their products for compliance with standards. Environmental pollution has even reached the pristine places. Even in an isolated location such as Mount Everest heavy metals Pb, Cd, Cr, As, and Hg were detected. found that all snow samples from Everest had As and Cd levels higher than the USEPA drinking water guidelines. Besides, all soil samples were highly polluted with As.

Heavy Metals Binding to Thiol Group

Following the entrance into the body, heavy metals can bind to lipids, proteins, and nucleic acids. Binding to enzymes and proteins commonly occurs through thiol (–SH) groups and modifies cysteine residues in proteins. As an example, reaction of Cd with the sulfhydryl group (–SH) in a protein is shown in Figure 3. Such protein inactivation is capable of disrupting the intracellular redox state. Consequently, an imbalanced antioxidant defense contributes to the development of liver injury. Similar reactions can occur with the other heavy metals. In complexation of heavy metals with thiol-containing proteins, the ligands are amino acids which contain the –SH functional group.

ROS Generation

Toxic metals are able to generate free radicals, mainly ROS and RNS, which can induce oxidative stress. For example, arsenic has been shown to produce superoxide (O2 −.), oxygen (O2.), nitric oxide (NO.), hydrogen peroxide (H2O2), and peroxyl (ROO.) radicals. Pb exposure significantly reduces antioxidant parameters GPx, CAT, SOD, GST, and GSH while it increases oxidative parameters MDA and H2O2. ROS and RNS generation induced by Cr (VI) depletes cellular antioxidant power which results in oxidative stress and consequently the toxicity of DNA, lipid, and proteins. Cd could indirectly generate O2 −., hydroxyl (OH), and NO. radicals which could overwhelm cells’ antioxidant defense. It is believed that the toxic effects of Hg on the CNS and cardiovascular system are related to the increase in ROS production. This causes a reduction in the activity of antioxidant enzymes: glutathione peroxidase, catalase, and SOD. Moreover, high affinity of Hg for –SH groups can lead to decreased glutathione peroxidase activity and also interference with intracellular signaling of many receptors. Furthermore, Me-Hg has the capacity to induce phospholipase D (PLD) activation. Increased PLD activity has been shown to be involved in many human cancers and diseases (Figure 4). Pb and Hg toxicity is mediated either directly via ROS production or indirectly through the depletion of cellular antioxidants. However, Cd is believed to generate ROS indirectly. This may be due to the replacement of iron and copper by Cd in cellular proteins. The oxidative stress is then as a result of excess Fe and Cu accumulation. Moreover, replacement of the essential minerals disrupts the cell's biological metabolism. Alternatively, Cd could disrupt the antioxidant glutathione which will eventually lead to oxidative stress.

The Carcinogenicity of Heavy Metals

The mechanism of carcinogenicity of heavy metals is unclear and complicated. Carcinogenicity of some heavy metals is assumed to be due to their bonding to regulatory proteins that are involved in cell cycle regulation, DNA synthesis and repair, and apoptosis. Besides, toxicogenomic investigations highlight the characterization of gene expressions after metal toxicity. Transcription factors such as Activator Protein 1 (AP-1), Nuclear Factor-kappa B (NF-κB), and p53 are targets for Cd and As. As a result, controlling the expression of protective genes failed, leading to uncontrolled cell growth and division. A few studies have examined Ras proteins mutations or increased activation in carcinogenic heavy metals exposure. showed overexpression of Ras in human prostate epithelial cells following As exposure. In another study, the elevation of the level of ERK 1/2, as well as transcription factors jun and fos, was observed in vitro by Cd. Cr (VI) also induced overexpression of jun in cultured cells. The mutated Ras protein loses its ability to be inactivated and the kinase cascade is not turned off. Besides, intensified jun and fos or activated ERK 1/2 continues repeatedly the gene expression. Thus, a permanently activated signaling pathway results in continuously activated proliferation, leading to increased tumor formation.

Arsenic is shown to inhibit DNA repair by inhibiting poly ADP-ribose polymerase 1 (PARP-1), a responsible enzyme for DNA break repair processes. Resistance to apoptosis due to heavy metals exposure breaks down a basic cell defense. It has been shown that Cd can induce malignant transformation of the prostate epithelial cell line through increased apoptotic resistance. Apoptotic resistance is attributed to the overexpression of Bcl-2 and disruption of a specific pathway of apoptosis known as the JNK pathway. Altered expression of genes involved in apoptosis and DNA repair is proposed for resistance to apoptosis induced by Cr6+. Moreover, hexavalent Cr causes DNA damage by inactivation of DNA ligase, DNA polymerase β, and PARP-1. Deficient DNA repair due to Cr leads to chromosome instability which is a key mechanism of Cr6+-induced carcinogenesis.

Epigenetic Mechanisms of Heavy Metals

Heavy metals can promote epigenetic alterations, including DNA methylation and histone modification. Hg, Pb, Cr, Cd, and As are capable of DNA methylation. Besides, Hg, Pb, Cr, and As can make histone alterations. However, there are no data available for Cd to induce histone modifications. On the other hand, only Cd and As are reported to mediate expression of noncoding RNAs, another molecular mechanism of epigenetic regulation. The exact mechanism of epigenetic changes due to heavy metals exposure is not fully determined. It seems that increased expression of protooncogenes and silencing of tumor suppresser genes via intracellular ROS production are the underlying causes. DNA methylation is well known to inhibit the expression of some tumor suppressors. As a result, changes in gene expression result in the alteration of the cellular division process and facilitation of malignant transformation of cells. Epigenetic dysregulations in human bronchial epithelial cells were reported following Cr6+ exposure. found increased levels of histone H3 methylation marks (H3K9me2 and H3K27me3) and histone methyltransferases (HMTases). Hu et al. reported Cr-induced methylation of the p16 gene, a tumor suppressor gene, in the same cell line. Similarly, epigenetic changes may attribute to the Cd and As toxic and carcinogenic effects. DNA methylation as well as specific histone modification marks are associated with exposure to Cd and As.

Comparison of the Mechanistic Action

Since there are multiple cellular targets, the mechanism underlying the toxicity of toxic heavy metals is complicated. It is understood that Hg, Pb, Cr, Cd, and As commonly exert their toxicity through similar pathways including ROS generation, weakening of the antioxidant defense, enzyme inactivation, and multiple organ toxicity. For instance, glutathione peroxidase and reductase are known enzymes which are inactivated by these five metals. However, some metals selectively bind to a specific protein as a unique mechanism of that metal. For example, Pb-induced anemia occurs via the inhibition of two enzymes of heme biosynthesis: ALAD and ferrochelatase (Figure 1). The interaction of protein phosphatases (PP) with Cd can be mentioned as another example. Examination of protein phosphatases 1 (PP1) metal inhibitors showed that Cd2+ and Hg2+ both have inhibitory effects on PP1 enzyme. However, Cd2+ is likely a potent and competitive inhibitor of the enzyme. Heavy metals can disrupt endocrine systems by interfering mainly with steroid and thyroid hormones in human and animals. As an example, Cd, Pb, and Cr are known to induce thyrotoxicosis. The mechanism of toxicity of these heavy metals and the organ toxicity are presented in Table 1.

While different types of mercury compounds are found in the environment, the organic forms of Hg are more toxic than the inorganic species. Hg can cause cognitive impairment and CNS injury. Besides, Hg causes renal dysfunction especially in the proximal tubules due to its preferential accumulation in the kidneys. It has also harmful effects on liver and the intestine.

The effect of proinflammatory cytokines in the brain following Pb exposure is inflammation in the CNS which in turn causes neurotoxicity. Pb has also shown to have hematotoxic and hepatotoxic effects. Moreover, it poses renal and respiratory harmful effects. Pb-induced renal toxicity might lead to necrosis. Apoptosis in lead toxicity takes place via the inhibition of Bcl-2 and the activation of caspase-3 following mitochondrial cytochrome C release. Lead neurotoxicity and cognitive impairment might be promoted via the inhibition of NMDA receptor and the blockage of neurotransmitter release.

Hexavalent chromium has been classified as a carcinogen. Cr toxicity can cause the lungs and upper respiratory cancers. Mechanisms of Cr toxicity and carcinogenicity are considered as DNA damage, genomic instability, and ROS generation. Following exposure and bioaccumulation of Cr, a variety of diseases appeared. Skin, hepatic, renal, reproductive, and neurological disorders can be mentioned. Moreover, many other cellular injuries and cell death as both apoptosis and necrosis may occur.

Like Cr, Cd is also classified as a carcinogen. Consequences of Cd poisoning might be painful degenerative bone disease, kidney failure, and the GI and lungs diseases. Cd can bind to MT and other metal transporters in the small intestine and accumulates in the GI tract. Altered miRNA expression due to Cd exposure may play a role in Cd-induced nephrotoxicity. Apoptosis is associated with the cytochrome C release into the cytosol due to Cd exposure.

Like chromium and cadmium, arsenic is considered a human carcinogen. Chronic arsenic toxicity or arsenicosis causes skin manifestations such as pigmentation and keratosis. Arsenic poisoning may exert obstructive and restrictive pulmonary diseases. Arsenic has been linked to cognitive dysfunction and neurological problems such as pricking sensation in hands and legs.

Conclusion

The heavy metals enter the body from different ways including drinking water, air, food, or occasionally dermal exposure. Following absorption, heavy metals are retained, and they accumulate in the human body. Bioaccumulation of toxic metals leads to a diversity of toxic effects on a variety of body tissues and organs. Metal toxicity can have acute or chronic manifestations. Heavy metals disrupt cellular events including growth, proliferation, differentiation, damage-repairing processes, and apoptosis. Toxic metals can also promote epigenetic alterations which can influence gene expression. Comparison of the mechanisms of action reveals similar pathways for these metals to induce toxicity including ROS generation, weakening of the antioxidant defense, enzyme inactivation, and oxidative stress. On the other hand, some researches have shown that the metals selectively bind to specific macromolecules. The interaction of Pb with ALAD and ferrochelatase is within this context. Reactions of other heavy metals with certain proteins were discussed as well. Some toxic metals including Cr, Cd, and As cause genomic instability. Defects in DNA repair following the induction of oxidative stress and DNA damage by these metals is considered as the cause of their carcinogenicity. The application of chelation therapy for the management of metal poisoning has not been reviewed here. This could be another aspect of heavy metals to be reviewed in the future. Developing specific biomarkers for monitoring heavy metals will be a major achievement in the field. Future research will benefit from the evaluation of new targets as protective procedures against organ toxicity induced by heavy metals.

References 187

  1. 1.

    Abdou H. M. Hassan M. A. (2014 ). Protective role of omega-3 polyunsaturated fatty acid against lead acetate-induced toxicity in liver and kidney of female rats. Biomed. Res. Int. 2014, 435857.

    Not in our library10.1155/2014/435857

  2. 2.

    Abirami N. Raju V. S. Rajathi K. (2007 ). Effect of Semecarpus anacardium against lead induced toxicity in rats. Anc. Sci. Life 27 (2), 24–27.

    Not in our library

  3. 3.

    Achmad R. T. Budiawan B. Ibrahim Auerkari E. (2017 ). Effects of chromium on human body. Annu. Res. Rev. 13, 1–8.

    Not in our library10.9734/arrb/2017/33462

  4. 4.
  5. 5.

    Akgül N. Altunkaynak B. Z. Altunkaynak M. E. Deniz Ö. G. Ünal D. Akgül H. M. (2016 ). Inhalation of mercury vapor can cause the toxic effects on rat kidney. Ren. Fail. 38 (3), 465–473.

    Not in our library10.3109/0886022x.2016.1138832

  6. 6.

    Aragão W. A. B. Teixeira F. B. Fagundes N. C. F. Fernandes R. M. Fernandes L. M. P. Da Silva M. C. F. (2018 ). Hippocampal dysfunction provoked by mercury chloride exposure: evaluation of cognitive impairment, oxidative stress, tissue injury and nature of cell death. Oxid. Med. Cell. Longev. 2018, 7878050.

    Not in our library10.1155/2018/7878050

  7. 7.
  8. 8.

    Ataei N. Aghaei M. Panjehpour M. (2019 ). Evidences for involvement of estrogen receptor induced ERK1/2 activation in ovarian cancer cell proliferation by cadmium chloride. Toxicol. In Vitro 56, 184–193.

    Not in our library10.1016/j.tiv.2019.01.015

  9. 9.

    Bailey K. A. Wu M. C. Ward W. O. Smeester L. Rager J. E. García-Vargas G. (2013 ). Arsenic and the epigenome: interindividual differences in arsenic metabolism related to distinct patterns of DNA methylation. J. Biochem. Mol. Toxicol. 27 (2), 106–115.

    Not in our library10.1002/jbt.21462

  10. 10.

    Batáriová A. Spěváčková V. Beneš B. Čejchanová M. Šmíd J. Černá M. (2006 ). Blood and urine levels of Pb, Cd and Hg in the general population of the Czech Republic and proposed reference values. Int. J. Hyg. Environ. Health 209 (4), 359–366.

    Not in our library10.1016/j.ijheh.2006.02.005

  11. 11.
  12. 12.

    Bodaghi-Namileh V. Sepand M. R. Omidi A. Aghsami M. Seyednejad S. A. Kasirzadeh S. (2018 ). Acetyl- l -carnitine attenuates arsenic-induced liver injury by abrogation of mitochondrial dysfunction, inflammation, and apoptosis in rats. Environ. Toxicol. Pharmacol. 58, 11–20.

    Not in our library10.1016/j.etap.2017.12.005

  13. 13.

    Bokare A. D. Choi W. (2011 ). Advanced oxidation process based on the Cr(III)/Cr(VI) redox cycle. Environ. Sci. Technol. 45 (21), 9332–9338.

    Not in our library10.1021/es2021704

  14. 14.

    Borowska S. Brzóska M. Gałażyn-Sidorczuk M. Rogalska J. (2017 ). Effect of an extract from aronia melanocarpa L. berries on the body status of zinc and copper under chronic exposure to cadmium: an in vivo experimental study. Nutrients 9 (12), 1374.

    Not in our library10.3390/nu9121374

  15. 15.

    Boskabady M. H. Tabatabai S. A. Farkhondeh T. (2016 ). Inhaled lead affects lung pathology and inflammation in sensitized and control Guinea pigs. Environ. Toxicol. 31 (4), 452–460.

    Not in our library10.1002/tox.22058

  16. 16.

    Bottino C. Vázquez M. Devesa V. Laforenza U. (2016 ). Impaired aquaporins expression in the gastrointestinal tract of rat after mercury exposure. J. Appl. Toxicol. 36 (1), 113–120.

    Not in our library10.1002/jat.3151

  17. 17.

    Bridges C. C. Zalups R. K. (2017 ). Mechanisms involved in the transport of mercuric ions in target tissues. Arch. Toxicol. 91 (1), 63–81.

    Not in our library10.1007/s00204-016-1803-y

  18. 18.

    Brown H. A. Thomas P. G. Lindsley C. W. (2017 ). Targeting phospholipase D in cancer, infection and neurodegenerative disorders. Nat. Rev. Drug Discov. 16 (5), 351.

    Not in our library10.1038/nrd.2016.252

  19. 19.

    Burford N. Eelman M. Groom K. (2005 ). Identification of complexes containing glutathione with As(III), Sb(III), Cd(II), Hg(II), Tl(I), Pb(II) or Bi(III) by electrospray ionization mass spectrometry. J. Inorg. Biochem. 99 (10), 1992–1997.

    Not in our library10.1016/j.jinorgbio.2005.06.019

  20. 20.

    Burki T. K. (2012 ). Nigeria’s lead poisoning crisis could leave a long legacy. Lancet 379 (9818), 792.

    Not in our library10.1016/s0140-6736(12)60332-8

  21. 21.

    Cancer (1993 ). Beryllium, cadmium, mercury, and exposures in the glass manufacturing industry. Working Group views and expert opinions, Lyon, 9-16 February 1993. IARC Monogr. Eval. Carcinog Risks Hum., 58, 1.

    Not in our library

  22. 22.

    Cao Z. R. Cui S. M. Lu X. X. Chen X. M. Yang X. Cui J. P. (2018 ). [Effects of occupational cadmium exposure on workers’ cardiovascular system]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 36(6), 474–477.

    Not in our library10.3760/cma.j.issn.1001-9391.2018.06.025

  23. 23.

    Cefalu W. T. Hu F. B. (2004 ). Role of chromium in human health and in diabetes. Diabetes Care 27 (11), 2741–2751.

    Not in our library10.2337/diacare.27.11.2741

  24. 24.

    Chen L. Jin T. Huang B. Chang X. Lei L. Nordberg G. F. (2006 ). Plasma metallothionein antibody and cadmium-induced renal dysfunction in an occupational population in China. Toxicol. Sci. 91 (1), 104–112.

    Not in our library10.1093/toxsci/kfj053

  25. 25.

    Chen J. Fok K. L. Chen H. Zhang X. H. Xu W. M. Chan H. C. (2012 ). Cryptorchidism-induced CFTR down-regulation results in disruption of testicular tight junctions through up-regulation of NF- B/COX-2/PGE2. Hum. Reprod. 27 (9), 2585–2597.

    Not in our library10.1093/humrep/des254

  26. 26.

    Chen C.-Y. Zhang S.-l. Liu Z.-Y. Tian Y. Sun Q. (2015 ). Cadmium toxicity induces ER stress and apoptosis via impairing energy homoeostasis in cardiomyocytes. Biosci. Rep. 35 (3), e00214.

    Not in our library10.1042/bsr20140170

  27. 27.

    Chen R. Xu Y. Xu C. Shu Y. Ma S. Lu C. (2019 ). Associations between mercury exposure and the risk of nonalcoholic fatty liver disease (NAFLD) in US adolescents. Environ. Sci. Pollut. Res. 26 (30), 31384–31391.

    Not in our library10.1007/s11356-019-06224-5

  28. 28.

    Chen X. Wang Z. Zhu G. Nordberg G. F. Jin T. Ding X. (2019 ). The association between cumulative cadmium intake and osteoporosis and risk of fracture in a Chinese population. J. Expo. Sci. Environ. Epidemiol. 29 (3), 435–443.

    Not in our library10.1038/s41370-018-0057-6

  29. 29.
  30. 30.

    Cheng J. P. Wang W. H. Jia J. P. Zheng M. Shi W. Lin X. Y. (2006 ). Expression of c-fos in rat brain as a prelude marker of central nervous system injury in response to methylmercury-stimulation. Biomed. Environ. Sci. 19 (1), 67–72.

    Not in our library

  31. 31.

    Cheng T.-F. Choudhuri S. Muldoon-Jacobs K. (2012 ). Epigenetic targets of some toxicologically relevant metals: a review of the literature. J. Appl. Toxicol. 32 (9), 643–653.

    Not in our library10.1002/jat.2717

  32. 32.

    Choi J. Bae S. Lim H. Lim J.-A. Lee Y.-H. Ha M. (2017 ). Mercury exposure in association with decrease of liver function in adults: a longitudinal study. J. Prev. Med. Public Health 50 (6), 377.

    Not in our library10.3961/jpmph.17.099

  33. 33.

    Choong G. Liu Y. Templeton D. M. (2014 ). Interplay of calcium and cadmium in mediating cadmium toxicity. Chem. Biol. Interact. 211, 54–65.

    Not in our library10.1016/j.cbi.2014.01.007

  34. 34.

    Chunhabundit R. (2016 ). Cadmium exposure and potential health risk from foods in contaminated area, Thailand. Toxicol. Res. 32 (1), 65–72.

    Not in our library10.5487/tr.2016.32.1.065

  35. 35.

    Clancy H. A. Sun H. Passantino L. Kluz T. Muñoz A. Zavadil J. (2012 ). Gene expression changes in human lung cells exposed to arsenic, chromium, nickel or vanadium indicate the first steps in cancer. Metallomics 4 (8), 784–793.

    Not in our library10.1039/c2mt20074k

  36. 36.

    Cobbina S. J. Chen Y. Zhou Z. Wu X. Zhao T. Zhang Z. (2015 ). Toxicity assessment due to sub-chronic exposure to individual and mixtures of four toxic heavy metals. J. Hazard. Mater. 294, 109–120.

    Not in our library10.1016/j.jhazmat.2015.03.057

  37. 37.

    Coogan T. P. Motz J. Snyder C. A. Squibb K. S. Costa M. (1991 ). Differential DNA-protein crosslinking in lymphocytes and liver following chronic drinking water exposure of rats to potassium chromate. Toxicol. Appl. Pharmacol. 109 (1), 60–72.

    Not in our library10.1016/0041-008x(91)90191-g

  38. 38.

    Costa M. (2019 ). Review of arsenic toxicity, speciation and polyadenylation of canonical histones. Toxicol. Appl. Pharmacol. 375, 1–4.

    Not in our library10.1016/j.taap.2019.05.006

  39. 39.

    Dadpour B. Afshari R. Mousavi S. R. Kianoush S. Keramati M. R. Moradi V. A. (2016 ). Clinical and laboratory findings of lead hepatotoxicity in the workers of a car battery manufacturing factory. Iranian J. Toxicol. 10 (2), 1–6.

    Not in our library

  40. 40.

    De Flora S. D’Agostini F. Balansky R. Micale R. Baluce B. Izzotti A. (2008 ). Lack of genotoxic effects in hematopoietic and gastrointestinal cells of mice receiving chromium (VI) with the drinking water. Mutat. Res. 659 (1-2), 60–67.

    Not in our library10.1016/j.mrrev.2007.11.005

  41. 41.

    Del Razo L. M. D. García-Vargas G. G. Albores A. Vargas H. Gonsebatt M. E. Montero R. (1997 ). Altered profile of urinary arsenic metabolites in adults with chronic arsenicism. Arch. Toxicol. 71 (4), 211–217.

    Not in our library10.1007/s002040050378

  42. 42.

    DeLoughery Z. Luczak M. W. Zhitkovich A. (2014 ). Monitoring Cr intermediates and reactive oxygen species with fluorescent probes during chromate reduction. Chem. Res. Toxicol. 27 (5), 843–851.

    Not in our library10.1021/tx500028x

  43. 43.

    Deng Y. Wang M. Tian T. Lin S. Xu P. Zhou L. (2019 ). The effect of hexavalent chromium on the incidence and mortality of human cancers: a meta-analysis based on published epidemiological cohort studies. Front. Oncol. 9, 24.

    Not in our library10.3389/fonc.2019.00024

  44. 44.

    Ding W. Liu W. Cooper K. L. Qin X.-J. de Souza Bergo P. L. Hudson L. G. (2009 ). Inhibition of poly(ADP-ribose) polymerase-1 by arsenite interferes with repair of oxidative DNA damage. J. Biol. Chem. 284 (11), 6809–6817.

    Not in our library10.1074/jbc.m805566200

  45. 45.

    Djordjevic V. R. Wallace D. R. Schweitzer A. Boricic N. Knezevic D. Matic S. (2019 ). Environmental cadmium exposure and pancreatic cancer: evidence from case control, animal and in vitro studies. Environ. Int. 128, 353–361.

    Not in our library10.1016/j.envint.2019.04.048

  46. 46.

    Dongre N. N. Suryakar A. N. Patil A. J. Ambekar J. G. Rathi D. B. (2011 ). Biochemical effects of lead exposure on systolic & diastolic blood pressure, heme biosynthesis and hematological parameters in automobile workers of north Karnataka (India). Ind. J. Clin. Biochem. 26 (4), 400–406.

    Not in our library10.1007/s12291-011-0159-6

  47. 47.

    Dos Santos A. A. Chang L. W. Liejun Guo G. Aschner M. (2018 ). “Chapter 35 - fetal Minamata disease: a human episode of congenital methylmercury poisoning,” in Handbook of developmental neurotoxicology. Editors Slikker W. Paule M. G. Wang C. 2nd Edn (Cambridge, MA: Academic Press), 399–406.

    Not in our library

  48. 48.

    Dutta K. Prasad P. Sinha D. (2015 ). Chronic low level arsenic exposure evokes inflammatory responses andDNA damage. Int. J. Hyg. Environ. Health 218 (6), 564–574.

    Not in our library10.1016/j.ijheh.2015.06.003

  49. 49.

    El-Sokkary G. H. Abdel-Rahman G. H. Kamel E. S. (2005 ). Melatonin protects against lead-induced hepatic and renal toxicity in male rats. Toxicol. 213 (1-2), 25–33.

    Not in our library10.1016/j.tox.2005.05.003

  50. 50.

    Fang Z. Zhao M. Zhen H. Chen L. Shi P. Huang Z. (2014 ). Genotoxicity of tri-and hexavalent chromium compounds in vivo and their modes of action on DNA damage in vitro. PloS One 9 (8), e103194.

    Not in our library10.1371/journal.pone.0103194

  51. 51.

    Farkhondeh T. Boskabady M. H. Kohi M. K. Sadeghi-Hashjin G. Moin M. (2014 ). Lead exposure affects inflammatory mediators, total and differential white blood cells in sensitized guinea pigs during and after sensitization. Drug Chem. Toxicol. 37 (3), 329–335.

    Not in our library10.3109/01480545.2013.866133

  52. 52.
  53. 53.
  54. 54.

    Ferreira L. M. R. Cunha-Oliveira T. Sobral M. C. Abreu P. L. Alpoim M. C. Urbano A. M. (2019 ). Impact of carcinogenic chromium on the cellular response to proteotoxic stress. Int. J. Mol. Sci. 20 (19), 4901.

    Not in our library10.3390/ijms20194901

  55. 55.

    Gazwi H. S. S. Yassien E. E. Hassan H. M. (2020 ). Mitigation of lead neurotoxicity by the ethanolic extract of Laurus leaf in rats. Ecotoxicol. Environ. Safe 192, 110297.

    Not in our library10.1016/j.ecoenv.2020.110297

  56. 56.

    Ghorani-Azam A. Riahi-Zanjani B. Balali-Mood M. (2016 ). Effects of air pollution on human health and practical measures for prevention in Iran. J. Res. Med. Sci., 21, 65.

    Not in our library10.4103/1735-1995.189646

  57. 57.

    Gorini F. Muratori F. Morales M. A. (2014 ). The role of heavy metal pollution in neurobehavioral disorders: a focus on autism. Rev. J. Autism Dev. Disord. 1 (4), 354–372.

    Not in our library10.1007/s40489-014-0028-3

  58. 58.

    Gupta D. K. Tiwari S. Razafindrabe B. Chatterjee S. (2017 ). “Arsenic contamination from historical aspects to the present,” in Arsenic Contamination in the Environment. Berlin, Germany: Springer, 1–12.

    Not in our library10.1007/978-3-319-54356-7_1

  59. 59.

    Gurer-Orhan H. Sabır H. U. Özgüneş H. (2004 ). Correlation between clinical indicators of lead poisoning and oxidative stress parameters in controls and lead-exposed workers. Toxicol. 195 (2-3), 147–154.

    Not in our library10.1016/j.tox.2003.09.009

  60. 60.

    Hazelhoff M. H. Torres A. M. (2018 ). Gender differences in mercury-induced hepatotoxicity: potential mechanisms. Chemosphere 202, 330–338.

    Not in our library10.1016/j.chemosphere.2018.03.106

  61. 61.

    Hopenhayn C. Ferreccio C. Browning S. R. Huang B. Peralta C. Gibb H. (2003 ). Arsenic exposure from drinking water and birth weight. Epidemiology 14, 593–602.

    Not in our library10.1097/01.ede.0000072104.65240.69

  62. 62.

    Hu G. Li P. Li Y. Wang T. Gao X. Zhang W. (2016 ). Methylation levels of P16 and TP53 that are involved in DNA strand breakage of 16HBE cells treated by hexavalent chromium. Toxicol. Lett. 249, 15–21.

    Not in our library10.1016/j.toxlet.2016.03.003

  63. 63.

    Jacobs D. E. Wilson J. Dixon S. L. Smith J. Evens A. (2009 ). The relationship of housing and population health: a 30-year retrospective analysis. Environ. Health Perspect. 117 (4), 597–604.

    Not in our library10.1289/ehp.0800086

  64. 64.

    Jadhav S. H. Sarkar S. N. Patil R. D. Tripathi H. C. (2007 ). Effects of subchronic exposure via drinking water to a mixture of eight water-contaminating metals: a biochemical and histopathological study in male rats. Arch. Environ. Contam. Toxicol. 53 (4), 667–677.

    Not in our library10.1007/s00244-007-0031-0

  65. 65.

    Jiang J. H. Ge G. Gao K. Pang Y. Chai R. C. Jia X. H. (2015 ). Calcium signaling involvement in cadmium-induced astrocyte cytotoxicity and cell death through activation of MAPK and PI3K/Akt signaling pathways. Neurochem. Res. 40 (9), 1929–1944.

    Not in our library10.1007/s11064-015-1686-y

  66. 66.

    Jolliffe D. M. Budd A. J. Gwilt D. J. (1991 ). Massive acute arsenic poisoning. Anaesthesia 46 (4), 288–290.

    Not in our library10.1111/j.1365-2044.1991.tb11500.x

  67. 67.

    Joseph C. L. M. Havstad S. Ownby D. R. Peterson E. L. Maliarik M. McCabe M. J. (2005 ). Blood lead level and risk of asthma. Environ. Health Perspect. 113 (7), 900–904.

    Not in our library10.1289/ehp.7453

  68. 68.

    Kasperczyk S. Birkner E. Kasperczyk A. Kasperczyk J. (2005 ). Lipids, lipid peroxidation and 7-ketocholesterol in workers exposed to lead. Hum. Exp. Toxicol. 24 (6), 287–295.

    Not in our library10.1191/0960327105ht528oa

  69. 69.

    Khazdair M. R. Boskabady M. H. Afshari R. Dadpour B. Behforouz A. Javidi M. (2012 ). Respiratory symptoms and pulmonary function testes in lead exposed workers. Iran. Red Crescent Med. J. 14 (11), 737.

    Not in our library10.5812/ircmj.4134

  70. 70.

    Kianoush S. Balali-Mood M. Mousavi S. R. Moradi V. Sadeghi M. Dadpour B. (2012 ). Comparison of therapeutic effects of garlic and d-penicillamine in patients with chronic occupational lead poisoning. Basic Clin. Pharmacol. Toxicol. 110 (5), 476–481.

    Not in our library10.1111/j.1742-7843.2011.00841.x

  71. 71.

    Kianoush S. Balali-Mood M. Mousavi S. R. Shakeri M. T. Dadpour B. Moradi V. (2013 ). Clinical, toxicological, biochemical, and hematologic parameters in lead exposed workers of a car battery industry. Iran J. Med. Sci. 38 (1), 30.

    Not in our library

  72. 72.

    Kianoush S. Sadeghi M. Balali-Mood M. (2015 ). Recent advances in the clinical management of lead poisoning. Acta Med. Iran 53, 327–336.

    Not in our library

  73. 73.

    Kim C.-Y. Watanabe C. Kasanuma Y. Satoh H. (1995 ). Inhibition of γ-glutamyltranspeptidase decreases renal deposition of mercury after mercury vapor exposure. Arch. Toxicol. 69 (10), 722–724.

    Not in our library10.1007/s002040050239

  74. 74.

    Kim H. S. Kim Y. J. Seo Y. R. (2015 ). An overview of carcinogenic heavy metal: molecular toxicity mechanism and prevention. J. Cancer Prev. 20 (4), 232.

    Not in our library10.15430/jcp.2015.20.4.232

  75. 75.

    Kim T. H. Kim J. H. Le Kim M. D. Suh W. D. Kim J. E. Yeon H. J. (2020 ). Exposure assessment and safe intake guidelines for heavy metals in consumed fishery products in the Republic of Korea. Environ. Sci. Pollut. Res. Int., 27, 33042–33051.

    Not in our library10.1007/s11356-020-09624-0

  76. 76.

    Koedrith P. Kim H. Weon J.-I. Seo Y. R. (2013 ). Toxicogenomic approaches for understanding molecular mechanisms of heavy metal mutagenicity and carcinogenicity. Int. J. Hyg. Environ. Health 216 (5), 587–598.

    Not in our library10.1016/j.ijheh.2013.02.010

  77. 77.

    Kuivenhoven M. Mason K. (2019 ). Arsenic (arsine) toxicity. Treasure Island, FL: StatPearls Publishing.

    Not in our library

  78. 78.

    Kungolos A. Aoyama I. Muramoto S. (1999 ). Toxicity of organic and inorganic mercury to Saccharomyces cerevisiae. Ecotoxicol. Environ. Saf. 43 (2), 149–155.

    Not in our library10.1006/eesa.1999.1767

  79. 79.

    Lech T. Sadlik J. K. (2017 ). Cadmium concentration in human autopsy tissues. Biol. Trace Elem. Res. 179 (2), 172–177.

    Not in our library10.1007/s12011-017-0959-5

  80. 80.

    Lee C.-H. Chen J.-S. Sun Y.-L. Liao W.-T. Zheng Y.-W. Chai C.-Z. (2006 ). Defective beta1-integrins expression in arsenical keratosis and arsenic-treated cultured human keratinocytes. J. Cutan. Pathol. 33 (2), 129–138.

    Not in our library10.1111/j.0303-6987.2006.00361.x

  81. 81.

    Lee J.-K. Choi Y.-L. Kwon M. Park P. J. (2016 ). Mechanisms and consequences of cancer genome instability: lessons from genome sequencing studies. Annu. Rev. Pathol. 11, 283–312.

    Not in our library10.1146/annurev-pathol-012615-044446

  82. 82.

    Lee M.-R. Lim Y.-H. Lee B.-E. Hong Y.-C. (2017 ). Blood mercury concentrations are associated with decline in liver function in an elderly population: a panel study. Environ. Health 16 (1), 17.

    Not in our library10.1186/s12940-017-0228-2

  83. 83.

    Li L. Chen F. (2016 ). Oxidative stress, epigenetics, and cancer stem cells in arsenic carcinogenesis and prevention. Curr. Pharmacol. Rep. 2 (2), 57–63.

    Not in our library10.1007/s40495-016-0049-y

  84. 84.

    Li Y. Zhang B. Yang L. Li H. (2013 ). Blood mercury concentration among residents of a historic mercury mine and possible effects on renal function: a cross-sectional study in southwestern China. Environ. Monit. Assess. 185 (4), 3049–3055.

    Not in our library10.1007/s10661-012-2772-0

  85. 85.

    Lie P. Du B. Chan H. M. Feng X. (2015 ). Human inorganic mercury exposure, renal effects and possible pathways in Wanshan mercury mining area, China. Environ. Res. 140, 198–204.

    Not in our library10.1016/j.envres.2015.03.033

  86. 86.

    Li L. Jiang B. Lai J. Dai W. R. Li X. Liu W. F. (2017 ). [Change in peripheral nervous conduction velocity in patients with occupational chronic mercury poisoning and related influencing factors]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 35 (8), 598–602.

    Not in our library10.3760/cma.j.issn.1001-9391.2017.08.011

  87. 87.

    Li R. Wu H. Ding J. Fu W. Gan L. Li Y. (2017 ). Mercury pollution in vegetables, grains and soils from areas surrounding coal-fired power plants. Sci. Rep. 7, 46545.

    Not in our library10.1038/srep46545

  88. 88.

    Li H. Fagerberg B. Sallsten G. Borné Y. Hedblad B. Engström G. (2019 ). Smoking-induced risk of future cardiovascular disease is partly mediated by cadmium in tobacco: Malmö Diet and Cancer Cohort Study. Environ. Health 18 (1), 56.

    Not in our library10.1186/s12940-019-0495-1

  89. 89.

    Liaw J. Marshall G. Yuan Y. Ferreccio C. Steinmaus C. Smith A. H. (2008 ). Increased childhood liver cancer mortality and arsenic in drinking water in northern Chile. Cancer Epidemiol. Biomarkers Prev. 17 (8), 1982–1987.

    Not in our library10.1158/1055-9965.epi-07-2816

  90. 90.

    Lin X. Peng L. Xu X. Chen Y. Zhang Y. Huo X. (2018 ). Connecting gastrointestinal cancer risk to cadmium and lead exposure in the Chaoshan population of Southeast China. Environ. Sci. Pollut. Res. Int. 25 (18), 17611–17619.

    Not in our library10.1007/s11356-018-1914-5

  91. 91.
  92. 92.

    Liu J. Qu W. Kadiiska M. B. (2009 ). Role of oxidative stress in cadmium toxicity and carcinogenesis. Toxicol. Appl. Pharmacol. 238 (3), 209–214.

    Not in our library10.1016/j.taap.2009.01.029

  93. 93.

    Liu C.-M. Ma J.-Q. Sun Y.-Z. (2012 ). Puerarin protects rat kidney from lead-induced apoptosis by modulating the PI3K/Akt/eNOS pathway. Toxicol. Appl. Pharmacol. 258 (3), 330–342.

    Not in our library10.1016/j.taap.2011.11.015

  94. 94.

    Ljubojevic M. Herak-Kramberger C. M. Hagos Y. Bahn A. Endou H. Burckhardt G. (2004 ). Rat renal cortical OAT1 and OAT3 exhibit gender differences determined by both androgen stimulation and estrogen inhibition. Am. J. Physiol. Renal. Physiol. 287 (1), F124–F138.

    Not in our library10.1152/ajprenal.00029.2004

  95. 95.
  96. 96.

    Lu T. Liu J. LeCluyse E. L. Zhou Y.-S. Cheng M.-L. Waalkes M. P. (2001 ). Application of cDNA microarray to the study of arsenic-induced liver diseases in the population of Guizhou, China. Toxicol. Sci. 59 (1), 185–192.

    Not in our library10.1093/toxsci/59.1.185

  97. 97.

    Luo J.-h. Qiu Z.-q. Zhang L. Shu W.-q. (2012 ). Arsenite exposure altered the expression of NMDA receptor and postsynaptic signaling proteins in rat hippocampus. Toxicol. Lett. 211 (1), 39–44.

    Not in our library10.1016/j.toxlet.2012.02.021

  98. 98.
  99. 99.

    Lv Y. Wang P. Huang R. Liang X. Wang P. Tan J. (2017 ). Cadmium exposure and osteoporosis: a population-based study and benchmark dose estimation in southern China. J. Bone Miner Res. 32 (10), 1990–2000.

    Not in our library10.1002/jbmr.3151

  100. 100.

    Ma L. Li J. Zhan Z. Chen L. Li D. Bai Q. (2016 ). Specific histone modification responds to arsenic-induced oxidative stress. Toxicol. Appl. Pharmacol. 302, 52–61.

    Not in our library10.1016/j.taap.2016.03.015

  101. 101.

    Macfie A. Hagan E. Zhitkovich A. (2010 ). Mechanism of DNA−Protein cross-linking by chromium. Chem. Res. Toxicol. 23 (2), 341–347.

    Not in our library10.1021/tx9003402

  102. 102.
  103. 103.

    Mense S. M. Zhang L. (2006 ). Heme: a versatile signaling molecule controlling the activities of diverse regulators ranging from transcription factors to MAP kinases. Cell Res. 16 (8), 681–692.

    Not in our library10.1038/sj.cr.7310086

  104. 104.

    Messner B. Türkcan A. Ploner C. Laufer G. Bernhard D. (2016 ). Cadmium overkill: autophagy, apoptosis and necrosis signalling in endothelial cells exposed to cadmium. Cell. Mol. Life Sci. 73 (8), 1699–1713.

    Not in our library10.1007/s00018-015-2094-9

  105. 105.

    Mishra K. P. Singh V. K. Rani R. Yadav V. S. Chandran V. Srivastava S. P. (2003 ). Effect of lead exposure on the immune response of some occupationally exposed individuals. Toxicology 188 (2-3), 251–259.

    Not in our library10.1016/s0300-483x(03)00091-x

  106. 106.

    Mishra K. P. (2009 ). Lead exposure and its impact on immune system: a review. Toxicol. In Vitro 23 (6), 969–972.

    Not in our library10.1016/j.tiv.2009.06.014

  107. 107.
  108. 108.

    Moitra S. Blanc P. D. Sahu S. (2013 ). Adverse respiratory effects associated with cadmium exposure in small-scale jewellery workshops in India. Thorax 68 (6), 565–570.

    Not in our library10.1136/thoraxjnl-2012-203029

  109. 109.

    Møller-Madsen B. (1992 ). Localization of mercury in CNS of the rat. Arch. Toxicol. 66 (2), 79–89.

    Not in our library10.1007/bf02342499

  110. 110.

    Moriarity R. J. Liberda E. N. Tsuji L. J. S. (2020 ). Subsistence fishing in the Eeyou Istchee (James Bay, Quebec, Canada): a regional investigation of fish consumption as a route of exposure to methylmercury. Chemosphere 258, 127413.

    Not in our library10.1016/j.chemosphere.2020.127413

  111. 111.

    Mousavi S. R. Balali-Mood M. Riahi-Zanjani B. Yousefzadeh H. Sadeghi M. (2013 ). Concentrations of mercury, lead, chromium, cadmium, arsenic and aluminum in irrigation water wells and wastewaters used for agriculture in Mashhad, northeastern Iran. Int. J. Occup. Environ. Med. 4 (2 April), 80–86.

    Not in our library

  112. 112.

    Mugahi M. N. Heidari Z. Sagheb H. M. Barbarestani M. (2003 ). Effects of chronic lead acetate intoxication on blood indices of male adult rat. DARU J. Pharm. Sci. 11 (4), 147–141.

    Not in our library

  113. 113.

    Namgung U. Xia Z. (2001 ). Arsenic induces apoptosis in rat cerebellar neurons via activation of JNK3 and p38 MAP kinases. Toxicol. Appl. Pharmacol. 174 (2), 130–138.

    Not in our library10.1006/taap.2001.9200

  114. 114.

    Neal A. P. Guilarte T. R. (2010 ). Molecular neurobiology of lead (Pb2+): effects on synaptic function. Mol. Neurobiol. 42 (3), 151–160.

    Not in our library10.1007/s12035-010-8146-0

  115. 115.

    Ngalame N. N. O. Tokar E. J. Person R. J. Xu Y. Waalkes M. P. (2014 ). Aberrant microRNA expression likely controls RAS oncogene activation during malignant transformation of human prostate epithelial and stem cells by arsenic. Toxicol. Sci. 138 (2), 268–277.

    Not in our library10.1093/toxsci/kfu002

  116. 116.

    Nickens K. P. Patierno S. R. Ceryak S. (2010 ). Chromium genotoxicity: a double-edged sword. Chem. Biol. Interact. 188 (2), 276–288.

    Not in our library10.1016/j.cbi.2010.04.018

  117. 117.

    Nishijo M. Nakagawa H. Suwazono Y. Nogawa K. Kido T. (2017 ). Causes of death in patients with Itai-itai disease suffering from severe chronic cadmium poisoning: a nested case–control analysis of a follow-up study in Japan. BMJ. Open 7 (7), e015694.

    Not in our library10.1136/bmjopen-2016-015694

  118. 118.

    O'Brien T. J. Witcher P. Brooks B. Patierno S. R. (2009 ). DNA polymerase zeta is essential for hexavalent chromium-induced mutagenesis. Mutat. Res. 663 (1-2), 77–83.

    Not in our library10.1016/j.mrfmmm.2009.01.012

  119. 119.

    Ohta H. Ohba K. (2020 ). Involvement of metal transporters in the intestinal uptake of cadmium. J. Toxicol. Sci. 45 (9), 539–548.

    Not in our library10.2131/jts.45.539

  120. 120.

    Omobowale T. O. Oyagbemi A. A. Akinrinde A. S. Saba A. B. Daramola O. T. Ogunpolu B. S. (2014 ). Failure of recovery from lead induced hepatoxicity and disruption of erythrocyte antioxidant defence system in Wistar rats. Environ. Toxicol. Pharmacol. 37(3), 1202–1211.

    Not in our library10.1016/j.etap.2014.03.002

  121. 121.

    Pan C. Liu H.-D. Gong Z. Yu X. Hou X.-B. Xie D.-D. (2013 ). Cadmium is a potent inhibitor of PPM phosphatases and targets the M1 binding site. Sci. Rep. 3, 2333.

    Not in our library10.1038/srep02333

  122. 122.

    Park S. J. Lee J. R. Jo M. J. Park S. M. Ku S. K. Kim S. C. (2013 ). Protective effects of Korean red ginseng extract on cadmium-induced hepatic toxicity in rats. J. Ginseng Res. 37 (1), 37.

    Not in our library10.5142/jgr.2013.37.37

  123. 123.

    Patlolla A. Tchounwou P. (2005 ). Serum acetyl cholinesterase as a biomarker of arsenic induced neurotoxicity in sprague-dawley rats. Int. J. Environ. Res. Public Health 2 (1), 80–83.

    Not in our library10.3390/ijerph2005010080

  124. 124.

    Patlolla A. K. Barnes C. Yedjou C. Velma V. R. Tchounwou P. B. (2009 ). Oxidative stress, DNA damage, and antioxidant enzyme activity induced by hexavalent chromium in Sprague-Dawley rats. Environ. Toxicol. 24 (1), 66–73.

    Not in our library10.1002/tox.20395

  125. 125.

    Patra R. C. Swarup D. Dwivedi S. K. (2001 ). Antioxidant effects of α tocopherol, ascorbic acid and l-methionine on lead induced oxidative stress to the liver, kidney and brain in rats. Toxicol. 162 (2), 81–88.

    Not in our library10.1016/s0300-483x(01)00345-6

  126. 126.

    Pavesi T. Moreira J. C. (2020 ). Mechanisms and individuality in chromium toxicity in humans. J. Appl. Toxicol. 40, 1183–1197.

    Not in our library10.1002/jat.3965

  127. 127.

    Perello G. Martí-Cid R. Llobet J. M. Domingo J. L. (2008 ). Effects of various cooking processes on the concentrations of arsenic, cadmium, mercury, and lead in foods. J. Agric. Food Chem. 56 (23), 11262–11269.

    Not in our library10.1021/jf802411q

  128. 128.

    Pesch B. Haerting J. Ranft U. Klimpel A. Oelschlägel B. Schill W. (2000 ). Occupational risk factors for renal cell carcinoma: agent-specific results from a case-control study in Germany. Int. J. Epidemiol. 29 (6), 1014–1024.

    Not in our library10.1093/ije/29.6.1014

  129. 129.

    Pham T. N. D. Marion M. Denizeau F. Jumarie C. (2006 ). Cadmium-induced apoptosis in rat hepatocytes does not necessarily involve caspase-dependent pathways. Toxicol. In Vitro 20 (8), 1331–1342.

    Not in our library10.1016/j.tiv.2006.05.005

  130. 130.

    Pi H. Xu S. Reiter R. J. Guo P. Zhang L. Li Y. (2015 ). SIRT3-SOD2-mROS-dependent autophagy in cadmium-induced hepatotoxicity and salvage by melatonin. Autophagy 11 (7), 1037–1051.

    Not in our library10.1080/15548627.2015.1052208

  131. 131.

    Pritchard D. E. Ceryak S. Ramsey K. E. O'brien T. J. Ha L. Fornsaglio J. L. (2005 ). Resistance to apoptosis, increased growth potential, and altered gene expression in cells that survived genotoxic hexavalent chromium [Cr (VI)] exposure. Mol. Cell. Biochem. 279 (1-2), 169–181.

    Not in our library10.1007/s11010-005-8292-2

  132. 132.

    Proshad R. Zhang D. Uddin M. Wu Y. (2020 ). Presence of cadmium and lead in tobacco and soil with ecological and human health risks in Sichuan province, China. Environ. Sci. Pollut. Res. Int. 27, 18355–18370.

    Not in our library10.1007/s11356-020-08160-1

  133. 133.

    Qu W. Ke H. Pi J. Broderick D. French J. E. Webber M. M. (2007 ). Acquisition of apoptotic resistance in cadmium-transformed human prostate epithelial cells: Bcl-2 overexpression blocks the activation of JNK signal transduction pathway. Environ. Health Perspect. 115 (7), 1094–1100.

    Not in our library10.1289/ehp.10075

  134. 134.

    Quershi I. Z. Mahmood T. (2010 ). Prospective role of ascorbic acid (vitamin C) in attenuating hexavalent chromium-induced functional and cellular damage in rat thyroid. Toxicol. Ind. Health 26 (6), 349–359.

    Not in our library10.1177/0748233710371109

  135. 135.

    Rahman A. Persson L.-Å. Nermell B. Arifeen S. E. Ekström E.-C. Smith A. H. (2010 ). Arsenic exposure and risk of spontaneous abortion, stillbirth, and infant mortality. Epidemiology 21, 797–804.

    Not in our library10.1097/ede.0b013e3181f56a0d

  136. 136.

    Rani A. Kumar A. Lal A. Pant M. (2014 ). Cellular mechanisms of cadmium-induced toxicity: a review. Int. J. Environ. Health Res. 24 (4), 378–399.

    Not in our library10.1080/09603123.2013.835032

  137. 137.

    Ratnaike R. N. (2003 ). Acute and chronic arsenic toxicity. Postgrad. Med. J. 79 (933), 391–396.

    Not in our library10.1136/pmj.79.933.391

  138. 138.
  139. 139.

    Salama A. Hegazy R. Hassan A. (2016 ). Intranasal chromium induces acute brain and lung injuries in rats: assessment of different potential hazardous effects of environmental and occupational exposure to chromium and introduction of a novel pharmacological and toxicological animal model. PLoS One 11 (12), e0168688.

    Not in our library10.1371/journal.pone.0168688

  140. 140.

    Salnikow K. Zhitkovich A. (2008 ). Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium. Chem. Res. Toxicol. 21 (1), 28–44.

    Not in our library10.1021/tx700198a

  141. 141.

    Sanders A. Smeester L. Rojas D. DeBussycher T. Wu M. Wright F. (2014 ). Cadmium exposure and the epigenome: exposure-associated patterns of DNA methylation in leukocytes from mother-baby pairs. Epigenetics 9 (2), 212–221.

    Not in our library10.4161/epi.26798

  142. 142.

    Saper R. B. Phillips R. S. Sehgal A. Khouri N. Davis R. B. Paquin J. (2008 ). Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet. JAMA 300 (8), 915–923.

    Not in our library10.1001/jama.300.8.915

  143. 143.

    Sattar A. Xie S. Hafeez M. A. Wang X. Hussain H. I. Iqbal Z. (2016 ). Metabolism and toxicity of arsenicals in mammals. Environ. Toxicol. Pharmacol. 48, 214–224.

    Not in our library10.1016/j.etap.2016.10.020

  144. 144.

    Schaefer H. R. Dennis S. Fitzpatrick S. (2020 ). Cadmium: mitigation strategies to reduce dietary exposure. J. Food Sci. 85 (2), 260–267.

    Not in our library10.1111/1750-3841.14997

  145. 145.

    Schnekenburger M. Talaska G. Puga A. (2007 ). Chromium cross-links histone deacetylase 1-DNA methyltransferase 1 complexes to chromatin, inhibiting histone-remodeling marks critical for transcriptional activation. Mol. Cell. Biol. 27 (20), 7089–7101.

    Not in our library10.1128/mcb.00838-07

  146. 146.
  147. 147.
  148. 148.

    Shah A. Q. Kazi T. G. Baig J. A. Arain M. B. Afridi H. I. Kandhro G. A. (2010 ). Determination of inorganic arsenic species (As3+ and As5+) in muscle tissues of fish species by electrothermal atomic absorption spectrometry (ETAAS). Food Chem. 119 (2), 840–844.

    Not in our library10.1016/j.foodchem.2009.08.041

  149. 149.

    Shalan M. G. Mostafa M. S. Hassouna M. M. El-Nabi S. E. H. El-Refaie A. (2005 ). Amelioration of lead toxicity on rat liver with vitamin C and silymarin supplements. Toxicology 206 (1), 1–15.

    Not in our library10.1016/j.tox.2004.07.006

  150. 150.

    Sharma P. Bihari V. Agarwal S. K. Verma V. Kesavachandran C. N. Pangtey B. S. (2012 ). Groundwater contaminated with hexavalent chromium [Cr (VI)]: a health survey and clinical examination of community inhabitants (Kanpur, India). PLoS One 7 (10), e47877.

    Not in our library10.1371/journal.pone.0047877

  151. 151.

    Shekhawat K. Chatterjee S. Joshi B. (2015 ). Chromium toxicity and its health hazards. Int. J. Adv. Res. 3 (7), 167–172.

    Not in our library

  152. 152.

    Shen S. Li X.-F. Cullen W. R. Weinfeld M. Le X. C. (2013 ). Arsenic binding to proteins. Chem. Rev. 113 (10), 7769–7792.

    Not in our library10.1021/cr300015c

  153. 153.

    Son Y.-O. Wang L. Poyil P. Budhraja A. Hitron J. A. Zhang Z. (2012 ). Cadmium induces carcinogenesis in BEAS-2B cells through ROS-dependent activation of PI3K/AKT/GSK-3β/β-catenin signaling. Toxicol. Appl. Pharmacol. 264 (2), 153–160.

    Not in our library10.1016/j.taap.2012.07.028

  154. 154.

    Struzynska L. Dąbrowska-Bouta B. Koza K. Sulkowski G. (2007 ). Inflammation-like glial response in lead-exposed immature rat brain. Toxicol. Sci. 95 (1), 156–162.

    Not in our library10.1093/toxsci/kfl134

  155. 155.

    Sujatha K. Srilatha C. Anjaneyulu Y. Rao T. Sreenivasulu D. Amaravathi P. (2011 ). Effect of lead acetate on sperm morphology and testis of wistar albino rats. Indian J. Anim. Reprod. 32 (2), 63–67.

    Not in our library

  156. 156.

    Tchounwou P. B. Yedjou C. G. Patlolla A. K. Sutton D. J. (2012 ). Heavy metal toxicity and the environment. Mol. Clin. Environ. Toxicol. 101, 133–164.

    Not in our library10.1007/978-3-7643-8340-4_6

  157. 157.

    Thevenod F. Chakraborty P. K. (2010 ). The role of Wnt/beta-catenin signaling in renal carcinogenesis: lessons from cadmium toxicity studies. Curr. Mol. Med. 10 (4), 387–404.

    Not in our library10.2174/156652410791316986

  158. 158.

    Thompson C. M. Proctor D. M. Haws L. C. Hébert C. D. Grimes S. D. Shertzer H. G. (2011 ). Investigation of the mode of action underlying the tumorigenic response induced in B6C3F1 mice exposed orally to hexavalent chromium. Toxicol. Sci. 123 (1), 58–70.

    Not in our library10.1093/toxsci/kfr164

  159. 159.

    Thompson C. M. Proctor D. M. Suh M. Haws L. C. Kirman C. R. Harris M. A. (2013 ). Assessment of the mode of action underlying development of rodent small intestinal tumors following oral exposure to hexavalent chromium and relevance to humans. Crit. Rev. Toxicol. 43 (3), 244–274.

    Not in our library10.3109/10408444.2013.768596

  160. 160.

    Tsai M.-T. Huang S.-Y. Cheng S.-Y. (2017 ). Lead poisoning can be easily misdiagnosed as acute porphyria and nonspecific abdominal painCase reports in emergency medicine 2017. Case Rep. Emerg Med. 2017 (2), 1–4.

    Not in our library10.3109/10408444.2013.768596

  161. 161.

    Urbano A. M. Ferreira L. M. R. Alpoim M. C. (2012 ). Molecular and cellular mechanisms of hexavalent chromium-induced lung cancer: an updated perspective. Curr. Drug. Metab. 13 (3), 284–305.

    Not in our library10.2174/138920012799320464

  162. 162.

    Vahter M. Åkesson A. Lidén C. Ceccatelli S. Berglund M. (2007 ). Gender differences in the disposition and toxicity of metals. Environ. Res. 104 (1), 85–95.

    Not in our library10.1016/j.envres.2006.08.003

  163. 163.

    Valko M. Morris H. Cronin M. (2005 ). Metals, toxicity and oxidative stress. Curr. Med. Chem. 12 (10), 1161–1208.

    Not in our library10.2174/0929867053764635

  164. 164.

    Velyka V. A. Pshak V. P. Lopushins’ka I. V. (2014 ). Activity of antioxidant enzymes of the rat kidneys under mercury dichloride effect. Ukr. Biochem. J. 86 (1), 124–130.

    Not in our library

  165. 165.

    Vincent J. B. (2017 ). New evidence against chromium as an essential trace element. J. Nutr. 147 (12), 2212–2219.

    Not in our library10.3945/jn.117.255901

  166. 166.

    Vincent J. B. (2019 ). Effects of chromium supplementation on body composition, human and animal health, and insulin and glucose metabolism. Curr. Opin. Clin. Nutr. Metab. Care 22 (6), 483–489.

    Not in our library10.1097/mco.0000000000000604

  167. 167.

    Wang X. Mandal A. K. Saito H. Pulliam J. F. Lee E. Y. Ke Z.-J. (2012 ). Arsenic and chromium in drinking water promote tumorigenesis in a mouse colitis-associated colorectal cancer model and the potential mechanism is ROS-mediated Wnt/β-catenin signaling pathway. Toxicol. Appl. Pharmacol. 262 (1), 11–21.

    Not in our library10.1016/j.taap.2012.04.014

  168. 168.

    Wang J. Zhu H. Yang Z. Liu Z. (2013 ). Antioxidative effects of hesperetin against lead acetate-induced oxidative stress in rats. Indian J. Pharmacol. 45 (4), 395–398.

    Not in our library10.4103/0253-7613.115015

  169. 169.

    Wang Y. Mandal A. K. Son Y.-O. Pratheeshkumar P. Wise J. T. F. Wang L. (2018 ). Roles of ROS, Nrf2, and autophagy in cadmium-carcinogenesis and its prevention by sulforaphane. Toxicol. Appl. Pharmacol. 353, 23–30.

    Not in our library10.1016/j.taap.2018.06.003

  170. 170.

    Wang Z. Wu J. Humphries B. Kondo K. Jiang Y. Shi X. (2018 ). Upregulation of histone-lysine methyltransferases plays a causal role in hexavalent chromium-induced cancer stem cell-like property and cell transformation. Toxicol. Appl. Pharmacol. 342, 22–30.

    Not in our library10.1016/j.taap.2018.01.022

  171. 171.

    Wasserman G. A. Liu X. Parvez F. Factor-Litvak P. Ahsan H. Levy D. (2011 ). Arsenic and manganese exposure and children’s intellectual function. Neurotoxicology 32 (4), 450–457.

    Not in our library10.1016/j.neuro.2011.03.009

  172. 172.

    Wells E. M. Bonfield T. L. Dearborn D. G. Jackson L. W. (2014 ). The relationship of blood lead with immunoglobulin E, eosinophils, and asthma among children: NHANES 2005–2006. Int. J. Hyg. Environ. Health 217 (2-3), 196–204.

    Not in our library10.1016/j.ijheh.2013.04.010

  173. 173.

    Wilhelm T. Said M. Naim V. (2020 ). DNA replication stress and chromosomal instability: dangerous liaisons. Genes (Basel) 11 (6), 642.

    Not in our library10.3390/genes11060642

  174. 174.

    Wise S. S. Wise J. P. (2012 ). Chromium and genomic stability. Mutat. Res. 733 (1-2), 78–82.

    Not in our library10.1016/j.mrfmmm.2011.12.002

  175. 175.

    Wise S. S. Aboueissa A. E.-M. Martino J. Wise J. P. (2018 ). Hexavalent chromium-induced chromosome instability drives permanent and heritable numerical and structural changes and a DNA repair-deficient phenotype. Cancer Res. 78 (15), 4203–4214.

    Not in our library10.1158/0008-5472.can-18-0531

  176. 176.

    Wu X. Cobbina S. J. Mao G. Xu H. Zhang Z. Yang L. (2016 ). A review of toxicity and mechanisms of individual and mixtures of heavy metals in the environment. Environ. Sci. Pollut. Res. Int. 23 (9), 8244–8259.

    Not in our library10.1007/s11356-016-6333-x

  177. 177.

    Xiao C. Liu Y. Xie C. Tu W. Xia Y. Costa M. (2015 ). Cadmium induces histone H3 lysine methylation by inhibiting histone demethylase activity. Toxicol. Sci. 145 (1), 80–89.

    Not in our library10.1093/toxsci/kfv019

  178. 178.

    Xu S. Pi H. Chen Y. Zhang N. Guo P. Lu Y. (2013 ). Cadmium induced Drp1-dependent mitochondrial fragmentation by disturbing calcium homeostasis in its hepatotoxicity. Cell Death Dis. 4 (3), e540.

    Not in our library10.1038/cddis.2013.7

  179. 179.
  180. 180.

    Yao H. Guo L. Jiang B.-H. Luo J. Shi X. (2008 ). Oxidative stress and chromium (VI) carcinogenesis. J. Environ. Pathol. Toxicol. Oncol. 27 (2), 77–82.

    Not in our library10.1615/jenvironpatholtoxicoloncol.v27.i2.10

  181. 181.

    Yasutake A. Sawada M. Shimada A. Satoh M. Tohyama C. (2004 ). Mercury accumulation and its distribution to metallothionein in mouse brain after sub-chronic pulse exposure to mercury vapor. Arch. Toxicol. 78 (9), 489–495.

    Not in our library10.1007/s00204-004-0572-1

  182. 182.

    Yeo B. Langley-Turnbaugh S. (2010 ). Trace element deposition on Mount Everest. Soil Surv. Horizons 51 (3), 72–78.

    Not in our library10.2136/sh2010.3.0072

  183. 183.

    Yu H.-S. Liao W.-T. Chai C.-Y. (2006 ). Arsenic carcinogenesis in the skin. J. Biomed. Sci. 13 (5), 657–666.

    Not in our library10.1007/s11373-006-9092-8

  184. 184.

    Zhang C. Gan C. Ding L. Xiong M. Zhang A. Li P. (2020 ). Maternal inorganic mercury exposure and renal effects in the Wanshan mercury mining area, southwest China. Ecotox. Environ. Safe. 189, 109987.

    Not in our library10.1016/j.ecoenv.2019.109987

  185. 185.

    Zhitkovich A. (2005 ). Importance of Chromium−DNA adducts in mutagenicity and toxicity of chromium(VI). Chem. Res. Toxicol. 18 (1), 3–11.

    Not in our library10.1021/tx049774+

  186. 186.

    Zhitkovich A. (2011 ). Chromium in drinking water: sources, metabolism, and cancer risks. Chem. Res. Toxicol. 24 (10), 1617–1629.

    Not in our library10.1021/tx200251t

  187. 187.

    Zuo Z. Cai T. Li J. Zhang D. Yu Y. Huang C. (2012 ). Hexavalent chromium Cr(VI) up-regulates COX-2 expression through an NFκB/c-jun/AP-1-dependent pathway. Environ. Health Perspect. 120 (4), 547–553.

    Not in our library10.1289/ehp.1104179

Cited by papers we hold 7

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.